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Cyclobutenes are good synthetic intermediates for their diversity and found in complex natural products 
and pharmaceuticals. Therefore, the development of synthetic method for cyclobutenes has attracted a 
lot of attention from the synthetic society. Because alkyne – alkene thermal [2+2] cycloaddition is a 
forbidden pathway, [2+2] cycloaddition of alkyne with alkene via UV activation has become an critical 
mean for the synthesis of cyclobutenes. While widely adopted, we were interested in exploration the 
complementary methods because the reaction with UV light has limited for an energy source. A variety 
of complementary methods for the formation of cyclobutenes using Lewis acids and transition metal 
catalysts have been studied. However, there is a limitation that certain functional groups are required 
on the substrates for activation. In a mean time, energy transfer (EnT) mechanism has been increasingly 
attracted attention as a substitute for visible-light photocatalysis in transformations. Here we developed 
[2+2] cycloaddition of alkyne with alkene through triplet energy transfer under visible light enabling 
the synthesis of various cyclobutenes via intermolecular reaction. Broad mechanism studies propose 
that the productive triplet excitation of alkenes in spite of the similar triplet energies of alkynes and 
alkenes can be explained by the localized spin densities on olefinic carbons. In addition, the 
intramolecular cycloaddition of enyne achieved the efficient synthesis for conjugated dienes through 
triplet tandem excitation of the formed cyclobutene products, that may provide an alternative approach 
to the transition metal-catalyzed ring closing enyne metathesis. 1,3-Dienes are useful intermediates in 
synthetic chemistry in that they can be easiely found in various transformations. Moreover, We have 
demonstrated the utility of our synthetic method by achieving several synthetic applications such as the 
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1.1. Cyclobutene in natural products and drugs 
 
 
Figure 1-1. Ring strain energies of cycloalkenes 
 
All-carbon small rings are important core structure found in many natural products and 
pharmaceuticals.1 Cyclobutene has a high ring strain energy following 2H-azirine among small rings, 
and is higher than cyclopropane (Figure 1-1). Cyclobutenes with complex substituents are difficult to 
synthesize because they are unstable due to their intrinsic ring strain. Indeed, the synthetic approaches 
for cyclobutene have been rarely reported compared to other four-membered rings such as cyclobutane 
and cyclobutanone, which can be easily obtained photochemically and thermally. Nevertheless, the 
synthetic methods of cyclobutene were strongly demanded because of high utility and synthetic value 
of cyclobutene. 
 
Figure 1-2. Natural and pharmaceutical products including cyclobutene 
 
Examples of natural and pharmaceutical products with cyclobutene as its core structure are shown in 
Figure 1-2. β-Lumicolchicine is known to prevent mitosis, COX-2 inhibitor is used as anti-
inflammatory analgesic drug, and cyclomegistine and fomannosin have antitumor and antiviral effects, 
respectively. Cyclobutene is also useful intermediate in that it can readily be transformed into other 
compounds due to its prominent reactivity. The conjugated 1,3-diene formed through ring opening 
reaction of cyclobutene by light or heat can be converted into a cyclohexene derivative after Diels-
Alder reaction. In addition, the unsaturated bond of cyclobutene allows a variety of reactions, including 




Figure 1-3. Various transformations of cyclobutene 
 
1.2. Synthesis of cyclobutene: Alkyne – alkene [2+2] cycloadditions 
Alkyne-alkene [2+2] cycloaddition is probably the most direct and effective approach to synthesize 
cyclobutene derivatives. According to Woodward-Hoffmann rule, the method is thermodynamically 
forbidden process in nature. However, the synthetic methods have been developed that are possible 
under certain conditions. They can be broadly classified into three categories2: 1) polarized [2+2] 
cycloaddition, 2) transition metal-catalyzed reaction, and 3) photocycloaddition. 
 
1.2.1. Polarized [2+2] cycloadditions 
Polarized [2+2] cycloaddition is a reaction that occurs due to the gap between the polarities of the 
substrates, which should have the properties of a nucleophile and an electrophile. The significant 
difference in their polarity allows them exceed the activation energy barrier to form four-membered 
ring. In this method, Lewis acids can be employed as catalysts to activate the electrophile toward 
nucleophilic attack or vice versa. This kind of reaction is well established to achieve the higher 
enantioselectivity of cyclobutene. In 1989, Narasaka et al. reported the first synthetic method for 
catalytic enantioselective [2+2] cycloaddition, which employed alkynyl sulfide as a substrate to attain 
the formation of cyclobutene (Scheme 1-1).3 In addition, alkenes containing unsaturated oxazolidinone, 
alkenyl and allenyl groups enable the synthesis of cyclobutane with excellent enantioselectivity. 
Unsubstituted, ester-substituted and unsaturated oxazolidinones are necessary to obtain high reactivity 
for [2+2] cycloaddition. The advantage that Lewis acid-catalyzed [2+2] cycloaddition of alkyne with 
alkene allows it to achieve excellent enantioselectivity of cyclobutene is useful for synthesizing natural 




Scheme 1-1. Catalytic enantioselective [2+2] cycloaddition by Narasaka et al. 
 
accomplishing [2+2] cycloaddition of cyclopentenone with alkynyl sulfide in 2004 (Scheme 1-2).4 Also, 
they synthesized (+)-precapnelladiene with the same approach to prove the utility of the synthetic 
method.5 Ishihara group achieved copper-catalyzed enantioselective cycloaddition of propiolamide with 
enol ether (Scheme 1-3).6  
 




Scheme 1-3. Copper catalyzed enantioselective cycloaddition by Ishihara et al. 
 
In 2011, Mezzetti et al. reported catalytic enantioselective [2+2] cycloaddition of ynamide with 
cyclopentenone, in other words, Ficini reaction (Scheme 1-4).7 Ficini reaction is the stepwise [2+2] 
cycloaddition of ynamine with cyclic enone by heating originally. Nakada group also reported a related 
Ficini reaction catalyzed by the chiral ligand in combination with Cu(OTf)2 as Lewis acid (Scheme 1-
5).8 In another study, a unique reactivity was elicited in the combination of In(tfacac)3 with TMSBr, 
resulting in the [2+2] cycloaddition of aryl alkyne with acrylate (Scheme 1-6).9 
 





Scheme 1-5. Modified Ficini reaction by Nakada et al. 
 
 
Scheme 1-6. Reactivity of combined Lewis acids 
 
1.2.2. Transition Metal Catalyzed Reactions 
 
Figure 1-4. Reaction mechanism of transition metal catalyzed [2+2] cycloaddition 
 
Many interesting reports of [2+2] cycloadditions have emerged in the field of transition metal catalyzed 
reactions. Mostly, the reaction mechanism is that five-membered ring intermediate was formed by 
oxidative cyclometallation of transition metal catalyst, and cyclobutene is produced via reductive 
elimination of the five-membered ring intermediate (Figure 1-4). In 2006, Shibata et al. reported 
enantioselective [2+2] cycloaddition of norbornene with alkynyl ester using rhodium complex (Scheme 





Scheme 1-7. Rh-catalyzed enantioselective [2+2] cycloaddition by Shibata et al. 
 
Shao group accomplished Ir-catalyzed enantioselective [2+2] cycloaddition of bicyclic alkene with 
terminal alkyne (Scheme 1-8).11 Fan et al. explained the mechanism by which 
[hydrido(acetylene)iridium(III)] complex 1 was first formed by the oxidative addition of the Ir 
catalyst.12 After migratory insertion, reinsertion and reductive elimination occurred sequentially, 
producing cyclobutene analogues. 
 
Scheme 1-8. Ir-catalyzed enantioselective cycloaddition by Shao and Fan groups 
 
Transition metal catalyzed [2+2] cycloaddition can be achieved not only Ir but also Ni catalyst. Ogoshi 
group, in 2012, attained intermolecular [2+2] cycloaddition of conjugated enyne with alkene (Scheme 
1-9).13 Conjugated enyne is essential in that the Ni(0) catalyst coordinates with the conjugated enyne 
and alkene when oxidative cyclization occurs to produce the η3-butadienyl nickelacycle intermediate 2. 
In this moment, the regioselectivity was determined by which intermediate was thermodynamically 





Scheme 1-9. Ni-catalyzed [2+2] cycloaddition by Ogoshi group 
 
Cramer group reported in 2017 Ru(II) based enantioselective [2+2] cycloaddition of norbornene and 
alkyne with chiral ligand (Scheme 1-10).14 It is remarkable that the reaction was previously proceeded 
using a cationic Ru(II) catalyst for catalysis, while a neutral Ru(II) catalyst with two open sites. 
 
Scheme 1-10. Ru-catalyzed enantioselective cycloaddition by Cramer et al. 
 
In 2018, RajanBabu group accomplished cobalt-catalyzed [2+2] cycloaddition to synthesize 
cyclobutene (Scheme 1-11).15 In addition, they converted cyclobutene to cyclobutane through one-pot 
tandem [2+2] cycloaddition using a single chiral cobalt catalyst, achieving the formation of three highly 





Scheme 1-11. Cobalt-catalyzed [2+2] cycloaddition by RajanBabu et al. 
 
Gold catalysts are also one of the useful transition metal catalysts for [2+2] cycloaddition. Sawamura 
group synthesized cyclobutenes fused with macrocycles via the intramolecular [2+2] cycloaddition of 
alkyne with alkene (Scheme 1-12).16 Although ring closing enyne metathesis can easily occur in 
transition metal catalyzed intramolecular reaction of enyne, it’s impressive that this method converts 
enyne to intact cyclobutene quite selectively. In another example of a reaction with gold, Liming Zhang 
et al. reported the [2+2] cycloaddition of alkynyl chloride with inactivated alkenes, which makes it 
possible to synthesize cyclobutene derivatives with easy access to conversion to a variety of complex 
compounds.17 
 
Scheme 1-12. Cyclobutene synthesis with gold catalyst by Zhang et al. 
 
1.2.3. Photochemical [2+2] Cycloadditions 
 [2+2] photocycloaddition has been developed for a long time and is used in a wide range of conditions 
from ultraviolet (UV) to visible light. In terms of the reaction mechanism, There are two main 
approaches known: direct absorption (excitation) of substrate using high energy ultraviolet light and 
energy/electron transfer using relatively low energy with photocatalyst.18 In case of direct excitation, 
olefin can be excited first from ground to singlet state (S1), and then directly undergoes addition onto 




Figure 1-5. Direct excitation under uv light 
 
In 2015, Carreira group synthesized the natural product (±)-Hippolachnin A by developing a UV light-
promoted [2+2] cycloaddition (Scheme 1-13).19 
 
Scheme 1-13. Total synthesis of Hippolachnin A 
 
There has been another study of intramolecular [2+2] cycloaddition using silyl-tethered enyne under 
UV light (Scheme 1-14).20 They proposed a mechanism that the alkyne moiety was first converted to 
diradical species based on the result that the alkyl and terminal alkynes were not converted to 
cyclobutene instead of aryl alkyne in control experiment. 
 
Scheme 1-14. Intramolecular [2+2] cycloaddition using silyl-tethered enyne under uv light 
 
In 2002, Oshima group demonstrated that the [2+2] cycloaddition of homobenzoquinone derivatives 
can be achieved with alkenes as well as alkynes (Scheme 1-15).21 It was inspiring that they introduced 




Scheme 1-15. [2+2] cycloaddition of homobenzoquinone derivatives with alkynes 
 
Recently, the studies on the [2+2] cycloaddition through energy transfer by photosensitizer have been 
developed enormously (Figure 1-6). Active olefins can be excited by light into a singlet state (S1), which 
goes through an inter system crossing (ISC) process to become triplet state (T1). When a photosensitizer 
is present, it first becomes triplet state by light, and then proceeds triplet energy transfer to the substrate.  
 
Figure 1-6. Reaction mechanism of triplet energy transfer 
 
The triplet state of the substrate is known to have the properties of diradical species, therefore it can 
undergo radical addition with another olefin or alkyne to form another diradical intermediate. The 
intermediate transforms to cyclobutane/cyclobutene through ring-closing after ISC. Compared to the 
singlet state of olefins, the triplet state is useful for intermolecular [2+2] cycloaddition because it has a 
long lifetime up to the μs unit. The studies on triplet energy transfer through UV absorption of 
maleimide and anhydride have been developed in abundance. Booker Milbern group, who has 
continued to work in this field, reported the synthesis of cyclobutene by excitation with UV light to the 
triplet state of 3,4,5,6-tetrahydrophthalic anhydride (THPA) and then [2+2] cycloaddition of THPA with 
propargyl alcohol (Scheme 1-16).22 In another study in the same group, they reported a method of 
synthesizing cyclobutene using fluoropolymer (FEP) tubes with excellent solvent resistance and UV 





Scheme 1-16. [2+2] cycloaddition of anhydride and maleimide under uv light 
 
Olefins can be excited to the triplet state using from UV-A (λ >360 nm) to visible (λ>400 nm) light 
under the influence of the process of metal ligand charge transfer (MLCT) of photocatalysts such as Ir 
and Ru or organic dyes as well as high energy UV light. Bach group accomplished a catalytic 
enantioselective [2+2] photocycloaddition using a modified xanthone 3 that can be excited by absorbing 
UV-A light (Scheme 1-17).24 
 
Scheme 1-17. Catalytic enantioselective [2+2] cycloaddition under uv-A light 
 
The triplet energy transfer method using a photosensitizer has the advantage of using visible light, which 
belongs to mild conditions, and thus has been vigorously advanced up to date. There have been many 
reports of visible light-promoted [2+2] cycloadditions between alkenes. In 2016, Yoon group reported 
that Lewis acid with chiral ligand can activate a photosensitizer electronically, which works for triplet 
energy transfer (Scheme 1-18).25 They used this approach for asymmetric [2+2] cycloadditions of 
hydroxychalcones with Ru catalyst as a photosensitizer. They proposed mechanism that the 
coordination of Lewis acid significantly reduce the triplet energy level of hydroxychalcone. The same 
group also reported a highly effective chiral photocatalyst that recruits prochiral quinolones using a 
series of hydrogen-bonding and π-π interactions.26 The association of the substrates within the chiral 
environment of the transition-metal photosensitizer allows expeditious stereo-induction and efficient 




Scheme 1-18. [2+2] cycloaddition using chiral Lewis acid complex and photosensitizer 
 
Wu group reported a general and simple method to realize the intermolecular [2+2] dimerization 
reaction of these acyclic olefins to construct cyclobutanes in a highly regio- and diastereoselective 
manner in solution under visible light (Scheme 1-19).27 The dimerization of chalcones and cinnamic 
acid derivatives is one of the unique strategies to synthesize cyclobutanes, that are building blocks for 
a variety of bioactive molecules and natural products. In 2018, the same group reported the visible light 
catalytic intermolecular [2+2] photocycloaddition of alkenes with enynes to alkynyl cyclobutanes, 
established with good functional group tolerance and high reaction efficiency and selectivity.28 It was 
found that enynes, including non-aromatics, can be sensitized by fac-Ir(ppy)3 via an energy transfer 
pathway. The addition of the Lewis acid PPh3AuNTf2 can lead to [2+2] photocycloaddition reactions 
under direct visible light irradiation or sensitization by Ru(bpy)3(PF6)2. Bach group prepared eniminium 
ions from the corresponding enones and enals, and found to promote to their respective triplet states by 
energy transfer (Scheme 1-20).29 The photoexcited intermediates underwent intra- or intermolecular 
[2+2] photocycloaddition in good yields under blue LEDs. The intermolecular [2+2] 
photocycloaddition of an eniminium ion derived from a chiral secondary amine proceeded with high 
enantioselectivity. In 2018, Glorius group reported the discovery and application of dearomative 
cascade photocatalysis as a strategy for the synthesis of complex molecules (Scheme 1-21).30 Visible-
light-absorbing photosensitizers were used to variably form two different polycyclic molecular 
scaffolds through catalytic selective energy transfer by sequentially activating 1-naphthol derived arene 
precursor. Recently, You group achieved intramolecular dearomatization of indole derivatives by 
employing [2+2] cycloaddition through energy transfer under visible light (Scheme 1-22).31 Highly 
29 
 
strained cyclobutene bearing tetracyclic spiroindolines, that was not normally available in thermal 




Scheme 1-19. [2+2] photocycloaddition by Wu et al. 
 
 
Scheme 1-20. Enantioselective [2+2] photocycloaddition of eniminium ion 
 
 





Scheme 1-22. Dearomative [2+2] cycloaddition by You et al. 
 
However, the [2+2] cycloaddition of alkenes with alkynes in visible light is rare. Recently, there have 
been a few studies reported in this area. Glorius group used an iridium photocatalyst under visible light 
for [2+2] cycloaddition of alkene with electron-rich alkynes to form cyclobutenes (Scheme 1-23).32 
 
Scheme 1-23. Alkyne-alkene [2+2] cycloaddition by Glorius et al. 
 
Maestri group attempted the intramolecular [2+2] cycloaddition of enyne to form cyclobutene as an 
intermediate, which was the expected reaction to synthesize bicyclo[2.2.0]hexane derivatives through 
sequential [2+2] cycloaddition with alkenes (Scheme 1-24).33 However, they obtained an unexpected 
molecule with two cyclopropane rings 4, and successfully demonstrated the reaction mechanism using 
DFT calculations. 
 
Scheme 1-24. Synthesis of bicyclo[2.2.0]hexane derivatives 
 




Figure 1-7. Stereoselectivity toward ring-opening of cyclobutene 
 
Over the past 20 years, the stereoselective electrocyclic ring opening of cyclobutenes has proven to be 
a useful strategy for a variety of synthetic pathways.34 The stereoselectivity toward ring-opening of 
cyclobutene can be controlled depending on whether it uses light or heat as an energy source. According 
to Woodward-Hoffmann rule (WH rule), the ring opening of cyclobutene can proceed through a 
conrotatory reaction mechanism by heat or a disrotatory reaction mechanism by light (Figure 1-7). The 
reason many chemists are eager to develop the ring-opening of cyclobutene is that it can convert 
cyclobutene to conjugated diene, which can be transformed into complex cyclic compounds by 
undergoing Diels-Alder reaction with alkenes or alkynes. There are examples for tandem reactions of 
ring-opening of cyclobutene and Diels-Alder reaction. Maulide group developed stereoselective 
domino synthesis of conjugated dienes in 2013 (Scheme 1-25).35 They used cyclobutene ring-fused 
lactone 5 as a substrate, then the lactone was subjected to domino allylic alkylation and 4π electrocyclic 
ring opening to produce functionalized butadiene. Diels-Alder reaction proceeded between butadiene 
and another alkene. Photochemical ring-opening of cyclobutene has been rarely reported compared to 
ring-closing reaction of 1,3-butadiene because most organic substrates can absorb light with 
wavelengths over 230 nm. In1985, the first photochemical ring opening reaction of cyclobutene was 
achieved by Adam group (Scheme 1-26).36 They observed four-photoproducts using 185 nm light in  
 




a pentane solution. Starting with Adam’s work, Clark and Leigh groups developed photochemical ring-
opening reaction in terms of stereochemistry. In 1987, they proved that WH rule was not always correct 
by obtaining conrotatory compounds, forbidden products under WH rule.37 
 











Visible Light-promoted [2+2] Cycloaddition 





2.1. Design of synthesis for cyclobutene 
 
Figure 2-1. Synthesis of cyclobutene via [2+2] cycloaddition under visible light 
 
For a long time, the [2+2] cycloaddition in visible light has been achieved only for alkenes through 
electron or energy transfer mechanism, and [2+2] cycloaddition of alkyne with alkene has been not 
clearly elucidated whether alkynes or alkenes were first activated by photocatalysts. We reported a 
visible light-promoted alkyne-alkene intermolecular [2+2] cycloaddition in photocatalysis to afford 
various cyclobutenes (Figure 2-1).38 Extensive mechanistic studies such as triplet quenching experiment, 
spin density and DFT calculation make sure that the productive activation of alkenes was demonstrated 
by localized electron densities on unsaturated carbons of alkenes. 
 
2.2. Reaction optimization of synthesis for cyclobutene 
We started the screening with Ir[dF(CF3)ppy]2(dtbbpy)PF6 (PC I) as a photocatalyst under blue light 
by using diaryl alkyne 6a and maleimide 7a as coupling partners (Table 2-1). All yields were determined 
by 1H NMR spectroscopic analysis against 1,1,2-trichloroethene as an internal standard. It turned out 
that the uses of 2.5 mol% PC I and nonpolar solvent (CH2Cl2 in 0.05 M) were optimal to afford desired 
cyclobutene product 8aa in 83% yield (entry 1). The reaction underwent with somewhat lower yields 
under conditions of lower catalyst-loading (1 mol%) and other concentrations (0.02 M and 0.1 M; entry 
2 – 4). In a change of solvents, a similar yield was shown when using chloroform instead of CH2Cl2 
(entry 5). Changing to THF and DMF also gave lower yield, 15 and 53% respectively (entry 6 – 7). 
Acetone solvent, which is known as a role of photosensitizer under UV light,39 gave 58% yield (entry 
8). We performed the reaction with a mixture of acetone and water to see moisture effect (entry 9). But 
it didn’t give any significant difference comparing to the reaction in acetone solvent. Moreover, the 
cycloaddition was sensitive under air, giving lower yield 48% (entry 10). It leaves the possibility of 
triplet-triplet energy transfer mechanism because oxygen is known as triplet quencher.40 To ensure that 
the photocatalysis derives intermolecular reactions, we performed several experiments as control, 




Table 2-1. Optimization of alkyne – alkene [2+2] cycloadditiona 
 
Entry Photocatalyst [mol%] 
E1/2(M*/M+)/E1/2(M*/M-) 
(V vs SCE) 
ET 
(kcal/mol) 
Solvent (M) Yield 
1 PC I [2.5] -0.89 / 1.21 60.8 CH2Cl2 (0.05) 
83% 
(76%b) 
2 PC I [1] -0.89 / 1.21 60.8 CH2Cl2 (0.05) 75% 
3 PC I [2.5] -0.89 / 1.21 60.8 CH2Cl2 (0.02) 80% 
4 PC I [2.5] -0.89 / 1.21 60.8 CH2Cl2 (0.1) 74% 
5 PC I [2.5] -0.89 / 1.21 60.8 CHCl3 (0.1) 73% 
6 PC I [2.5] -0.89 / 1.21 60.8 THF (0.1) 15% 
7 PC I [2.5] -0.89 / 1.21 60.8 DMF (0.1) 53% 
8 PC I [2.5] -0.89 / 1.21 60.8 acetone (0.1) 58% 
9c PC I [2.5] -0.89 / 1.21 60.8 acetone/H2O (0.05) 60% 
10d PC I [2.5] -0.89 / 1.21 60.8 CH2Cl2 (0.05) 48% 
11 - - - CH2Cl2 (0.05) trace 
12e PC I [2.5] -0.89 / 1.21 60.8 CH2Cl2 (0.05) n.r. 
a Reactions were conducted under argon atmosphere with 0.05 mmol scale. 8aa is a racemic. n.r. = no reaction. b Isolated yield 
after 4 h. c acetone : H2O = 9:1. d Reaction was conducted under air. e Reaction was conducted in the dark. 
 
[2+2] cycloaddition of alkene with alkyne is a forbidden reaction in thermal condition, however, a few 
[2+2] cycloadditions of reactive alkyne with alkene have been reported.41, 42 To make sure that the 
reaction is driven by photo-reaction, we performed another control experiment in thermal condition. 
When 6a and 7a heated up to reflux in 1,2-dichloroethane soluion without photocatalyst and blue LED, 




Scheme 2-1. Thermal condition of [2+2] cycloaddition of alkene with alkyne 
 
At this moment, we examined the underlying properties allowing the reactivity of photocatalysts, such 
as various iridium photocatalysts (PC I – PC VI), ruthenium catalyst and organic dye (Table 2-2). To 
figure out which mechanism would be operative between two possible reaction processes, one is energy 
transfer and the other is electron transfer, we compared the triplet energy and redox potential of alkene 
7a (ET = 55.9 kcal/mol and Ep/2
red
 = -1.16 V vs. SCE) with those of photocatalysts. The yields of 
cyclobutene 8aa have good correlation with the triplet energy levels of the photocatalysts, but their 
redox properties didn’t appear to be related to the results of the reaction. For instance, PC I with the 
highest triplet energy proved that it is the most effective catalyst for the reaction (ET = 60.8 kcal/mol), 
 
Table 2-2. Screening of catalysts for alkyne – alkene [2+2] cycloadditiona 
 
Entry Photocatalyst [mol%] 
E1/2(M*/M+)/E1/2(M*/M-) 




1 PC I [5] -0.89 / 1.21 60.8 76% 
2 PC II [5] -1.23 / 1.40 60.5 74% 
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3 PC III [5] -0.97 / 0.97 60.4 74% 
4 PC IV [5] -0.93 / 1.14 55.4 62% 
5 PC V [5] -1.04 / 1.07 53.0 35% 
6 PC VI [5] -0.96 / 0.66 49.2 trace 
7 Ru(bpy)3(PF6)2 [5] -0.81 / 0.77 46.5 n.r. 
8b Eosin Y [5] -1.11 / 0.83 43.6 n.r. 
a Reactions were conducted under argon atmosphere with 0.05 mmol scale. 8aa is a racemic. n.r. = no reaction. b Green LED 
was used, not blue one. 
while its reduction potential is not sufficient for the reduction of maleimide 7a (E1/2 (M*/M
+) = -0.89 V 
vs. SCE). When PC VI with somewhat higher reduction potential but a triplet energy much lower than 
that of 7a was used (E1/2 (M*/M
+) = -0.96 V vs. SCE and ET = 49.2 kcal/mol), a trace conversion was 
shown. In the same manner, a similar trend was shown for 6a (ET = 56.7 kcal/mol and Ep/2
red
 = -2.5 V, 
Ep/2
ox
 = 1.59 V vs. SCE) as well, indicating that the yields correlated well with the triplet energy levels 
of photocatalysts comparing to their redox potentials. These results do not clearly explain which 
counterpart of alkene and alkyne undergoes productive triplet excitation, but led us to suggest that the 
energy transfer process is working for the [2+2] cycloaddition of alkene with alkyne. 
 
2.3. Substrate Scope for Intermolecular [2+2] Cycloaddition 
The scope of intermolecular reaction was investigated with the optimized conditions. First, the steric 
and electronic effects were investigated by reacting substituted diarylalkynes with alkene 7a. It turned 
out that all alkynes which have electron-rich or deficient were tolerated well (Table 2-3, 8aa – 8ha). 
The usefulness of biologically active heterocyclic compounds motivated us to investigate alkynes 
substituted with pyridines and pyrazines. We were pleased with the fact that these heterocyclic alkynes 
reacted easily to provide desired products in good yields (8ia – 8ka). Moreover, the reaction of 
cyclopropyl arylalkyne 6l and alkene 7a afforded 8la with the cyclopropyl ring intact in 67% yield. 
Alkynes substituted with alkyl groups as well as the aryl substitution were investigated. We were 
gratified to know that the reaction of dialkylalkynes 6m and 6n underwent to give the desired products 
8ma and 8na. Furthermore, both alkynes substituted silyl group and substituted free 6o – 6u readily 
worked well during the reaction. In addition, we were interested in whether the reaction could endure 
alkynes with carboxylic acid and free hydroxy groups, that would make precluding protection chemistry. 
Substrates 6s and 6u certainly provided cyclobutene 8si and 8ua in good yields. The reaction of 





Table 2-3. Scope of alkyne moiety for alkyne – alkene [2+2] cycloaddition 
 
Unless other noticed, all reactions were performed under blue light using 12 W LED strip and argon gas with 0.1 mmol scale; 
Isolated yields; all cyclobutenes are racemic. a Reaction time : 1 – 18 h b Reaction time : 24 – 48 h 
 
We also examined the reactivity of the alkene moiety and it was turned out that good conversion can 
be achieved with alkenes bearing electron withdrawing groups. Hence, those functional groups 
including anhydride, amide, ester, and nitrile were turned out to be efficient for the reaction (Table 2-
4, 8ab – 8cg). A variety of N-substituted maleimides were participated in the reaction to figure out the 
concrete steric and electronic effects of maleimides for cycloaddition. It was found that N-H free and 
N-cyclohexyl maleimides 7h and 7i provided the desired products 8ah and 8ai in good yield. A variety 
of other N-substituents for maleimides with N-benzyloxyl, (p-cyano)phenyl and (p-methylester)phenyl 
groups were allowed to give cycloadducts in moderate to good yields (8aj – 8al). Besides, cyclobutene 
containing N-heteroarene could be obtained using maleimide 7n. 
Moreover, while investigating the scope of maleimides, yields of cyclobutenes were shown in broad 




Table 2-4. Scope of alkene moiety for alkyne – alkene [2+2] cycloaddition 
 
Unless other noticed, all reactions were performed under blue light using 12 W LED strip and argon gas with 0.1 mmol scale; 
Isolated yields; All cyclobutenes are racemic. a Reaction time : 1 – 18 h b Reaction time : 24 – 48 h c Reaction time : 53 h – 3 
d d Obtained as N-benzylamide form by one-pot addition with benzylamine reagent after finishing cycloaddition; Two-step 
yield. e Reaction time : 5 d; 15 equiv of alkene was added into the reaction and PC III was used not PC I. 
 
reaction effectiveness and electronic effect (Figure 2-2). There was a clear correlation; In general, the 
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lower yields were obtained from the reaction using N-aryl maleimides compared to those of N-alkyl 
maleimides 7i, in that case the low electron density of the unsaturated carbons seems to be caused by 
electronic delocalization to the aromatic ring. On the contrary, electron deficient aryl maleimides 7k 
and 7l gave higher yields. It has also good agreement with their electronic effects. 
Furthermore, we investigated the substitution influence on maleimide’s olefinic part. The maleimides 
7o – 7r substituted with halogen, methoxy and alkyl groups afforded the cycloadducts in outstanding 
yields. However, maleimide 7s substituted with dimethyl group gave the corresponding cyclobutene in 
moderate yield apparently because of steric effect. The cycloaddition of alkene 7t prepared using L-
alanine proceeded well, affording cyclobutene 8at in 93% yield. While acyclic mono-activated alkenes 
like methyl cinnamate failed to afford the desired cycloadduct (Scheme 2-2, 8au), cyclic alkenes of 
mono-activation containing lactam 8av and coumarins (8aw – 8xw) gave moderate to good yields. In 
addition, a highly substituted cyclobutene 8ax with a quaternary center was obtained in good yield 
(76%). We conjecture that the miscarriage for the reaction using acyclic mono-activated alkenes can be 
ascribed for quenching of catalyst due to E/Z isomerization. In the meantime, the reaction of 6a with 
7w was compared with the reaction under UV light. We found that the reactions under both UV light 
254 nm and 365 nm were sluggish giving 17% and 3% yields, respectively. (Scheme 2-3). In addition, 
late stage functionalization toward mercantile pharmaceuticals bearing alkyne groups underwent well 
when using acetyl protected 17α-ethynylestradiol and Efavirenz, resulting 8ya and 8za in good yields. 
17α-ethynylestradiol is an estrogen medication which is used widely in birth control pills in 
combination with progestins. It was widely used for the treatment of menopausal symptoms, 
gynecological disorders, and certain hormone-senstive cancers. It is usually taken by mouth. Efavirenz 
is an antiretroviral medication used to treat and prevent HIV/AIDS. It may be used for prevention after 
a needlestick injury or other potential exposure. It is taken by mouth once a day. 
 
 





Scheme 2-2. Scope of failed alkenes 
 
 
Scheme 2-3. Reactions under uv irradiation 
 
2.4. Synthetic Applications of Cyclobutene 
A variety of transformation more illustrated the synthetic application of cyclobutenes. First, we tried 
Johnson-Claisen rearrangement that is the reaction of an allylic alcohol with an orthoester to yield a γ, 
δ-unsaturated ester (Scheme 2-4). Pivalic acid was used to catalyze this reaction. Exomethylene 
cyclobutane 9 was successfully prepared from allylic alcohol 8qa. This rearrangement required high 
temperature (110 oC) to complete. Furthermore, γ-lactam and pyrrolidine were readily prepared by the 
reducing cyclobutenes 8aa and 8ca fused succinimide moiety. 
 




The transformation of cyclobutene can be extended when utilizing unsaturated double bond (Figure 2-
3). A trial of ozonolysis gave diketone 12 with 75% yield. It can be further transformed to bicyclic 
compounds via Paal-Knorr synthesis, which is a reaction that generates either furans, pyrroles, or 
thiophenes from 1,4-diketones. The reaction of cyclobutene 8ca with m-chloroperbenzoic acid (mCPBA) 
gave epoxide 13 to form three-four-five-membered tricyclic rings. It can undergo ring contraction 
treated by Lewis acid to afford cyclopropane ring 14 in 82% yield. The cyclobutene 8ae synthesized 
from diethyl fumarate 7e and di(p-tolyl)acetylene 6a can be converted to 1,3-dienes 15 via 4π-
electrocyclic ring opening under high temperature. We tried not only normal but also inverse electron-
demand Diels-Alder reactions of diene with several condition, but both failed to give cyclohexene 
product. 
 
Figure 2-3. Various transformations of cyclobutene 
 
2.5. Mechanism Study of [2+2] Cycloaddition of Alkyne with Alkene 
To find out whether a radical chain process is involved in the reaction, light on-off experiments were 
proceeded for the intermolecular reaction (Figure 2-4). The reaction stopped without light in the 




Figure 2-4. Light on-off experiments on intermolecular reaction 
 
The measurement of quantum yield for the intermolecular cycloaddition of 6a with 7a was also 
performed. The quantum yield 0.91 supports that the reaction isn’t radical chain reaction. To further 
corroborate that the triplet energy transfer mechanism is in operation for the reaction, the experiments 
using benzil (ET = 53.4 kcal/mol) as triplet quencher were proceeded, and it was turned out that the 
reaction gave significantly lower yield in 30% comparing to standard reaction (Scheme 2-5). Another 
triplet quenching experiment with TEMPO (ET = 52 kcal/mol) also afforded cyclobutene product in low 
yield. TEMPO is generally known as radical scavenger. The reaction of maleimide 7a alone with 
TEMPO gave a mixture of 7a and TEMPO attached adduct. We couldn’t separated two compounds but 
we obtained 1H NMR and MS data of the mixture. Also the reaction of di(p-tolyl)acetylene 6a alone 
with TEMPO didn’t give any expected product, only remaining alkyne 6a. There is reported that the 
triplet state of alkene is diradical species. we speculated that alkene would be excited to triplet state by 
photocatalyst because the diradical intermediate of alkene 7a was captured by TEMPO. However it’s 
not certain because we couldn’t obtain TEMPO attached product 16 during the alkyne – alkene [2+2] 




Scheme 2-5. Experiment of triplet quenchers 
 
The photo-reactions without counterparts were performed to figure out which substrate is activated by 
photocatalyst (Scheme 2-6). While the reaction of alkyne 6a alone didn’t afford any product, N-methyl 
maleimide 7a dimerized to form cyclobutane 17 when subjected to the condition. This result proposed 
the possibility that alkene is excited to the triplet state in photocatalysis. 
 
Scheme 2-6. Control experiments without counterpart 
 
We also performed Stern-Volmer quenching experiment with various photocatalysts using 6a and 7a 
as quenchers, investigating the relation of catalyst quenching with triplet energy level or with redox 
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property (Figure 2-5). The degree of catalyst quenching by 6a showed nice consensus for the triplet 
energy levels, not the reduction and oxidation potentials, that PC I with the most effective triplet energy 
level is shown as the best photocatalyst for the reaction. The same tendency was observed for the 
quenching by 7a, although the degree of catalyst quenching was less effective than that by 6a. These 
results show that the reaction is promoted through triplet energy transfer. 
 
 
Figure 2-5. Stern-Volmer plot using 6a and 7a as quenchers 
 
Due to the similar triplet energy levels of alkyne 6a (56.7 kcal/mol) and 7a (55.9 kcal/mol), It remains 
a question that which moieties achieves the productive triplet activation. Alkyne 6a seems to be better 
one as a quencher than alkene 7a in Stern-Volmer quenching experiment. It may propose that triplet 
alkynes would participate in [2+2] cycloaddition, not alkenes. On the other hand, Quenching of standard 
photocatalyst by alkyne 6m was not shown Because the alkyne 6m has higher triplet energy 74.1 
kcal/mol than that of photocatalyst. However the reaction of alkyne 6m with 7a affords the 
corresponding cyclobutene product in 56% (Figure 2-6). This result gave only one possibility that 
alkene would be excited to its triplet state in photocatalysis. 
To further determine the counterpart for the productive triplet excitation, radical clock experiments 
were performed (Scheme 2-7). Prepared each cyclopropyl alkyne 6l and cyclopropyl maleimide 7y was 
reacted with 7a and 6a, respectively. The reaction of 6l with 7a afforded the cyclobutene 8la in 67% 
yield. However, the reaction of cyclopropyl maleimide 7y with 6a gave the isomerized product 7y’ 
along with cyclobutene 8ay in low yields. Moreover, The reaction of cyclopropyl maleimide 7y alone 
afforded 7y’ in 73% yield in the standard condition. On the contrary, no reaction was observed when 
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using cyclopropyl alkyne 6l alone. The reason that the ring opening of 7y occured during excitation 
while the cyclopropyl ring of triplet alkyne 6l remains intact would be its less radical properties 
 
Figure 2-6. Stern-Vomer plot with 6m and 7a 
 
 
Scheme 2-7. Radical clock experiments 
 
on the carbon directly substituted cyclopropyl group of triplet alkyne 6l. (The rate constant of ring 
47 
 
opening of α-(2-phenylcyclopropyl)vinyl radicals ((1.6 ± 0.2) × 1010 s−1) was reported. It is higher than 
the one of its carbinyl radical (9.4 × 107 s−1))43, 44 
We proposed a plausible reaction pathway based on above experiments (Figure 2-7). This is an 
energetically feasible process. Triplet energy transfer occurs from Ir photocatalyst to alkene 7a under 
visible light. Triplet diradical intermediate 7a* undergoes radical addition on to diarylalkynes 6a to 
afford Int-8aa, which can be transformed to cyclobutene 8aa after inter system crossing process. 
 
 
Figure 2-7. Reaction mechanism of intermolecular reaction 
 
2.6. Conclusion 
We achieved intermolecular [2+2] cycloaddition of alkyne with alkene through triplet energy transfer 
under visible light. The synthesis of cyclobutenes was attained in the intermolecular reactions. It is 
worth pointing out that alkene undergoes cycloaddition with alkyne overcoming dimerization although 
alkene dimerization in photocatalysis is well known. The intermolecular reaction of a wide range of 
alkynes with alkenes including electron deficient groups underwent smoothly to give the corresponding 
cycloadducts. Mono-activated acyclic alkenes fail to form cyclobutene products but we accomplished 
the mono-activated alkene reaction with cyclic forms such as coumarin. We can infer from a variety of 
experiments that between alkynes and alkenes, alkenes react with alkynes, which is ground state, 
through productive activation to its triplet state. Moreover, we attained successful synthetic applications 
of cyclobutene such as rearrangement, ozonolysis, epoxidation and 4π electrocyclic ring opening to 
give good accessibilities toward complex molecules. 
 
2.7. Experimental Procedure and Data 
Optimization procedure : In a dried 4 mL vial, di(p-tolyl)acetylene 6a (0.05 mmol, 1.0 equiv.), N-
methylmaleimide 7a (1.5 equiv.), and catalyst Ir[dF(CF3)ppy]2(dtbbpy)PF6 (PC I) were added. The 
heterogenic mixture was dissolved in solvents under Ar gas in glovebox. And then the solution was 
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irradiated under 12 W blue LED strip at ambient temperature maintained with a cooling fan. The 
solution was put under nitrogen blow after finishing reaction with monitoring by TLC technique.  1H 
NMR analysis decided the yield of desired product from the mixture using trichloroethylene as the 
internal standard in CDCl3. 
 
General procedure A (cyclobutenes synthesis) 
In a dried 4 mL vial, alkyne (1.0 equiv., 0.1 mmol), alkene (1.5 equiv.), and photocatalyst 
Ir[dF(CF3)ppy]2(dtbbpy)PF6 (2.5 mol%) were added. The heterogenic mixture was dissolved in CH2Cl2 
(2 mL) under Ar gas in glovebox. The solution was then irradiated under 12 W blue LED strip at ambient 
temperature maintained with a cooling fan. The solution was put under nitrogen blow after finishing 
reaction with monitoring by TLC technique. Column Flash chromatography separated the residue on 




To a solution of cyclobutene 8qa (0.1 mmol, 1.0 equiv.) in triethyl orthoacetate (0.2 M, 0.5 mL) was 
added a catalytic quantity of trimethylacetic acid (0.1 equiv.) at rt. The solution was stirred at 110 °C 
for 1 day. The solution was washed using saturated aqueous NaHCO3 and extracted using CH2Cl2. The 
collected DCM solution was dehydrated using sodium sulfate anhydrous, filtered and dried under 
vacuum. Flash chromatography separated the residue using silica column to give the desired product 9. 
18 mg, 60% yield; colorless liquid; 1H NMR (400 MHz, CDCl3) δ 4.16 (q, J = 7.1 Hz, 2H), 3.90 (d, J 
= 6.1 Hz, 1H), 3.34 (d, J = 3.5 Hz, 1H), 3.14 (dd, J = 6.1, 3.0 Hz, 1H), 2.97 (s, 3H), 2.74 (dd, J = 15.5, 
4.2 Hz, 1H), 2.60 (dd, J = 15.5, 9.3 Hz, 1H), 2.21 (s, 2H), 2.00 – 1.85 (m, 2H), 1.49 (s, 6H), 1.27 (t, J 
= 7.5 Hz, 3H) ; 13C NMR (100 MHz, CDCl3) δ 178.0, 176.3, 170.9, 141.8, 121.9, 60.7, 45.4, 41.5, 41.0, 
38.5, 30.0, 29.6, 27.5, 27.4, 26.0, 25.1, 14.2; HRMS m/z calculated for [C17H24NO4]
+ ([M+H]+): 




Synthesis of 3-methyl-6,7-di-p-tolyl-3-azabicyclo[3.2.0]hept-6-en-2-one (10) 
 
To a solution of cyclobutene 8aa (1.0 equiv., 0.1 mmol) in dry THF/EtOH (0.1 M, 0.3 mL/0.7 mL) was 
slowly added NaBH4 (1.3 equiv.) at 0 °C under N2 flow and stirred the mixture overnight at room 
temperature. When TLC indicated the reaction was complete, the solution was adjusted to slightly acidic 
pH with glacial acetic acid (few drops), then concentrated in vacuo. The resulting mixture was diluted 
in EtOAc, washed with sat. NaHCO3 solution and extracted with EtOAc. The collected EA solution was 
dehydrated using sodium sulfate anhydrous, filtered and evaporated the solvent in vacuo. To the 
hydroxylactam prepared above was added triethylsilane (1.5 equiv.) followed by TFA (0.5 mL, 0.2 M). 
The reaction was stirred at rt for overnight under nitrogen flow. When TLC indicated the process was 
complete, the solvent was evaporated in vacuo. Flash chromatography separated the residue using silica 
column to obtain desired product. 21 mg, 69% yield; white solid; m.p. 88 – 90 °C; 1H NMR (400 MHz, 
CDCl3) δ 7.73 (d, J = 8.1 Hz, 2H), 7.42 (d, J = 7.9 Hz, 2H), 7.17 (d, J = 7.9 Hz, 2H), 7.13 (d, J = 8.0 
Hz, 2H), 3.72 (d, J = 4.2 Hz, 1H), 3.66 (ddd, J = 8.4, 4.4, 2.0 Hz, 1H), 3.49 (dd, J = 10.2, 8.4 Hz, 1H), 
3.33 (dt, J = 10.2, 1.8 Hz, 1H), 2.80 (s, 3H), 2.37 (s, 3H), 2.34 (s, 3H); 13C NMR (100 MHz, DMSO-
d6) δ 172.2, 140.9, 139.6, 138.0, 137.8, 131.4, 130.4, 129.4, 129.0, 126.4, 126.3, 49.0, 46.6, 34.0, 29.7, 
21.0, 21.0; HRMS m/z calculated for [C21H22NO]
+ ([M+H]+): 304.1696, observed : 304.1697 
 
Synthesis of 3-methyl-6,7-diphenyl-3-azabicyclo[3.2.0]hept-6-ene (11) 
 
To a slurry of LiAlH4 (3.9 equiv.) in Et2O (0.25 mL, 0.2 M) was added solution of cyclobutene 8ca (0.05 
mmol, 1.0 equiv.) in CH2Cl2 (0.5 mL, 0.1 M) at 0°C under nitrogen. The mixture was stirred at room 
temperature for 1 hour, and H2O was carefully added at 0 °C. To reaction suspension was hydrated using 
Na2SO4, filtered and evaporated the solvent in vacuo. Column Flash chromatography separated the 
residue on silica gel to give the desired product. 9 mg, 69% yield; yellow oil; 1H NMR (400 MHz, 
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CDCl3) δ 7.59 – 7.54 (m, 4H), 7.34 – 7.28 (m, 4H), 7.27 – 7.21 (m, 2H), 3.54 (d, J = 6.0 Hz, 2H), 3.14 
(d, J = 9.9 Hz, 2H), 2.36 (s, 3H), 2.08 – 1.98 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 139.0, 134.4, 
128.4, 128.0, 126.5, 55.5, 44.1, 42.2.; HRMS m/z calculated for [C19H20N]
+ ([M+H]+): 262.1590, 
observed 262.1592. 
 
Effect of Triplet Quencher 
In an dried 4 mL vial, di(p-tolyl)acetylene 6a (0.05 mmol, 1.0 equiv.), N-methylmaleimide 7a (1.5 
equiv.), photocatalyst Ir[dF(CF3)ppy]2(dtbbpy)PF6 (2.5 mol%) and triplet quencher benzil (1.0 equiv.) 
were equipped. The combined materials were dissolved in CH2Cl2 (2 mL) under argon atmosphere in 
glovebox. The reaction mixture was then irradiated by 12 W blue LED lamp at room temperature 
(maintained with a cooling fan) for 4 hours. Under reduced pressure, the solvent was evaporated. 1H 
NMR analysis decided the yield of desired product from the mixture using trichloroethylene as the 
internal standard in CDCl3; 30% yield. 
 




Prepared according to the General Procedure A using 1-(cyclopropylethynyl)-4-methylbenzene 6l (0.1 
mmol, 1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 18 mg, 67% yield; white solid; m.p. 98 – 
100 °C; 1H NMR (400 MHz, CDCl3) δ 7.53 (d, J = 8.2 Hz, 2H), 7.18 (d, J = 8.3 Hz, 2H), 3.89 (d, J = 
3.5, 1H), 3.50 (d, J = 3.5 Hz, 1H), 2.94 (s, 3H), 2.35 (s, 3H), 1.96 – 1.89 (m, 1H), 1.16 – 1.10 (m, 1H), 
1.00 – 0.80 (m, 3H) 13C NMR (100 MHz, CDCl3) δ 175.7, 175.5, 143.1, 138.8, 138.2, 130.5, 129.5, 
126.3, 43.8, 24.9, 21.5, 11.4, 6.8, 6.5; HRMS m/z calculated for [C17H18NO2]
+ ([M+H]+): 268.1332, 




Di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.), 3-cyclopropyl-1-methyl-1H-pyrrole-2,5-dione 7y (1.5 
equiv.), and photocatalyst Ir[dF(CF3)ppy]2(dtbbpy)PF6 (2.5 mol%) were added to an oven-dried 4 mL 
vial equipped with a stir bar. The combined materials were dissolved in CH2Cl2 (2 mL) under argon 
atmosphere in glovebox. The reaction mixture was then irradiated by 12 W blue LED lamp at room 
temperature (maintained with a cooling fan) for 48 hours. the solvent was evaporated in vacuo. Flash 
chromatography separated the residue using silica column to give 8ay (19% yield) and 7y′ (17% yield). 
c) 
3-cyclopropyl-1-methyl-1H-pyrrole-2,5-dione 7y (1.0 equiv.) and photocatalyst 
Ir[dF(CF3)ppy]2(dtbbpy)PF6 (2.5 mol%) were added to an oven-dried 4mL vial equipped with a stir bar. 
The combined materials were dissolved in CH2Cl2 (2 mL) under argon atmosphere in glovebox. The 
reaction mixture was then irradiated by 12 W blue LED lamp at room temperature (maintained with a 
cooling fan) for 4 hours. the solvent was evaporated in vacuo. Flash chromatography separated the 
residue using silica column to give 7y′ (73% yield). 
1-(cyclopropylethynyl)-4-methylbenzene 6l (0.1 mmol, 1.0 equiv.) and photocatalyst 
Ir[dF(CF3)ppy]2(dtbbpy)PF6 (2.5 mol%) were added to an oven-dried 4mL vial equipped with a stir bar. 
The combined materials were dissolved in CH2Cl2 (2 mL) under argon atmosphere in glovebox. The 
reaction mixture was then irradiated by 12 W blue LED lamp at room temperature (maintained with a 
cooling fan) for 48 hours. the solvent was evaporated in vacuo. The reaction wasn’t processed. (By 
using 1H NMR analysis of residues, the result was decided in CDCl3.) 
 
Quantum Yield Measurement 
Determination of the light intensity at 436 nm 
The effective photon flux of the used fluorometer was determined using standard ferrioxalate 
actinometry. A 0.15 M ferrioxalate solution was prepared by dissolving potassium ferrioxalate hydrate 
(221 mg, 0.45 mmol) in 0.05 M H2SO4 (3 mL). A buffer solution of 1,10-phenanthroline was prepared 
by dissolving 1,10-phenanthroline (10 mg, 0.055 mmol) and sodium acetate (2.25 g) in 0.5 M H2SO4 
(10 mL). The ferrioxalate solution (0.4 mL) was added to cuvette and was irradiated at 436 nm for 90 s 
in the fluorometer. After irradiation, the phenanthroline solution (0.07 mL) was added to the cuvette 
and the mixture was allowed in the absence of light for 1 h to achieve full phenanthroline coordination 
to the ferrous ions. In addition, a non-irradiated sample was prepared similarly. 
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The absorbance of both samples was measured at 510 nm. From these values, conversion could be 
determined using Lambert-Beer’s law : 
  𝒏(𝐅𝐞𝟐+) =
∨ . 𝜟𝑨
𝒍 . 𝛆
                                   (1) 
Where V is the total volume (0.47 mL) of the solution after addition of phenanthroline, l is the optical 
path length of the cuvette (1.00 cm), ε is the molar absorptivity of the ferrioxalate actinometer (11,100 
L mol-1 cm-1) and ΔA is the absorbance difference between the irradiated at 436 nm and non-irradiated 
sample (1.305). 




. 𝒕 . 𝒇
                                 (2) 
Where ΦF is the quantum yield of the ferrioxalate system (1.01 for 0.15 M solution at λex = 436 nm), t 
is the irradiation time (90.0 s) and f is the fraction of light absorbed at λex = 436 nm (0.9987, See 
Supplementary Equation 3). The absorption fraction is calculated as : 
f = 1-10-A                                     (3) 
Where A in Supplementary Equation 3 is the measured absorbance of ferrioxalate solution at 436 nm. 
It was measured to be 2.873. 
The photon flux Φq was calculated (average of two experiments) to be 6.09×10
-10 einstein s-1. 
Determination of quantum yield 
 
A cuvette was charged with alkyne 6a (0.025 mmol, 1 equiv.), alkene 7a (2 equiv.), 
Ir[dF(CF3)ppy]2(dtbbpy)PF6 (2.5 mol%), and CH2Cl2 (0.5 mL, 0.05 M) in Ar charged glovebox. The 
sample was sealed with parafilm and irradiated (λ = 436 nm, slit width = 20.0 nm) for 7,200 s (2 h). 
After irradiation, the solvent was evaporated with a stream of nitrogen. The yield of product 8aa formed 
was determined by 1H NMR based on a trichloroethylene as internal standard. The quantum yield 






. 𝒕 . 𝒇
                                 (4) 
The absorbance of photocatalyst in CH2Cl2 was measured at the reaction concentration of 1.25×10
-3 M. 
The absorbance at 436 nm is 1.91 indicating the fraction of light absorbed (f) is 0.9877. 
The quantum yield Φ was calculated (The yields of product 3aa are 15% and 16% in two experiments) 
to be 0.91. 
 
Stern-Volmer luminescence quenching experiments 
Stern-Volmer luminescence quenching studies were carried out using a 0.1 mM solution of 
photocatalyst and variable concentrations of substrate in dry DCM under Ar gas at rt. The samples were 
prepared in 0.5 mL quartz cuvettes inside an argon filled glove-box, and sealed with parafilm. The 
solutions were irradiated at 420 nm and the luminescence was measured at maximum emission 
wavelength of each photocatalyst. (I0 = emission intensity of the photocatalyst in isolation at the 
specified wavelength; I = observed intensity as a function of the quencher concentration) 
 
Electrochemical measurements with cyclic voltammogram 
Electrochemical measurement : 
Samples for electrochemical measurements were prepared with 0.03 mmol of substrate in anhydrous 
degassed 0.1 M Bu4NPF6 solution in MeCN (3 mL). The corresponding cyclic voltammograms were 
collected by a Potentiostat equipped with reference electrode (3 M KCl Ag/AgCl), counter electrode 
(platinum wire) and working electrode (glassy carbon), and 100 mV/s (scan rate); Data were analyzed 
by subtracting the electrolyte solution background current prior to identifying the maximum current 
(Cp) and determining the potential (Ep/2) at half this value (Cp/2). The obtained value was referenced to 






ox = +1.59 V vs SCE, Ep/2
red = -2.50 V vs SCE 
 
Ep/2






























Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and N-methylmaleimide 7a (1.5 equiv.), 24 mg, 76% yield; white solid; m.p. 134 – 135 °C; 1H NMR 
(400 MHz, CDCl3) δ 7.64 (d, J = 8.2 Hz, 4H), 7.18 (d, J = 7.9 Hz, 4H), 4.06 (s, 2H), 2.97 (s, 3H), 2.37 
(s, 6H); 13C NMR (100 MHz, CDCl3) δ 175.2, 139.2, 138.3, 130.3, 129.3, 126.8, 44.9, 24.8, 21.4; 
HRMS m/z calculated for [C21H20NO2]




Prepared according to the General Procedure A using 1,2-di-o-tolylethyne 6b (0.1 mmol, 1.0 equiv.) 
and N-methylmaleimide 7a (1.5 equiv.), 30 mg, 95% yield; white solid; m.p. 202 – 203 °C; 1H NMR 
(400 MHz, CDCl3) δ 7.46 (dd, J = 7.2, 1.7 Hz, 2H), 7.25 – 7.12 (m, 6H), 4.16 (s, 2H), 3.02 (s, 3H), 
2.01 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 175.2, 141.9, 136.4, 133.7, 130.8, 129.0, 128.5, 126.0, 
47.1, 25.1, 20.9; HRMS m/z calculated for [C21H20NO2]




Prepared according to the General Procedure A using 1,2-diphenylethyne 6c (0.1 mmol, 1.0 equiv.) 
and N-methylmaleimide 7a (1.5 equiv.), 18 mg, 62% yield; white solid; m.p. 129 – 130 °C;  1H NMR 
(400 MHz, CDCl3) δ 7.76 – 7.73 (m, 4H), 7.41 – 7.31 (m, 6H), 4.10 (s, 2H), 2.98 (s, 3H) 
13C NMR (100 
MHz, CDCl3) δ 175.1, 139.4, 133.0, 129.4, 128.8, 127.0, 45.2, 25.0; HRMS m/z calculated for 
[C19H16NO2]






Prepared according to the General Procedure A using 1,2-bis(4-methoxyphenyl)ethyne 6d (0.1 mmol, 
1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 19 mg, 54% yield; white solid; m.p. 131 – 132 °C; 
1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 8.9 Hz, 4H), 6.90 (d, J = 8.9 Hz, 4H), 4.04 (s, 2H), 3.83 (s, 
6H), 2.97 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 175.6, 160.1, 136.7, 128.4, 126.1, 114.2, 55.5, 45.0, 
24.9; HRMS m/z calculated for [C21H20NO4]




Prepared according to the General Procedure A using 1,2-bis(2-methoxyphenyl)ethyne 6e (0.1 mmol, 
1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 17 mg, 49% yield; white solid; m.p. 178 – 179 °C; 
1H NMR (400 MHz, CDCl3) δ 7.48 (dd, J = 7.6, 1.7 Hz, 2H), 7.27 (ddd, J = 8.3, 7.4, 1.7 Hz, 2H), 6.93 
(td, J = 7.5, 1.0 Hz, 2H), 6.83 (d, J = 8.3 Hz, 2H), 4.19 (s, 2H), 3.53 (s, 6H), 2.98 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ 175.7, 157.3, 138.0, 129.9, 129.5, 123.7, 120.0, 110.3, 54.9, 46.9, 24.9; HRMS 
m/z calculated for [C21H20NO4]
+ ([M+H]+): 350.1387 , observed : 350.1387 
 
Dimethyl 4,4'-(3-methyl-2,4-dioxo-3-azabicyclo[3.2.0]hept-6-ene-6,7-diyl)dibenzoate (8fa) 
 
Prepared according to the General Procedure A using dimethyl 4,4'-(ethyne-1,2-diyl)dibenzoate 6f (0.1 
mmol, 1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 30 mg, 74% yield; white solid; m.p. 207 – 
57 
 
209 °C; 1H NMR (400 MHz, CDCl3) δ 8.06 (d, J = 8.7 Hz, 4H), 7.80 (d, J = 8.7 Hz, 4H), 4.17 (s, 2H), 
3.94 (s, 6H), 3.00 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 174.4, 166.5, 140.7, 136.6, 130.9, 130.2, 
127.1, 52.4, 45.4, 25.2; HRMS m/z calculated for [C23H20NO6]





Prepared according to the General Procedure A using 1-bromo-2-(phenylethynyl)benzene 6g (0.1 
mmol, 1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 26 mg, 71% yield; white solid; m.p. 150 – 
151 °C; 1H NMR (400 MHz, CDCl3) δ 7.65 (d, J = 8.0 Hz, 1H), 7.48 – 7.46 (m, 2H), 7.38 – 7.23 (m, 
6H), 4.30 (d, J = 3.4 Hz, 1H), 4.18 (d, J = 3.4 Hz, 1H), 3.00 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
174.8, 174.6, 143.2, 138.7, 134.6, 133.4, 132.1, 130.5, 130.2, 129.5, 128.7, 127.8, 127.0, 122.6, 47.4, 
45.2, 25.0; HRMS m/z calculated for [C19H15BrNO2]





Prepared according to the General Procedure A using 2,2,2-trifluoro-N-(2-
(phenylethynyl)phenyl)acetamide 6h (0.1 mmol, 1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 
35 mg, 88% yield; yellow viscous oil; 1H NMR (400 MHz, CDCl3) 8.38 (s, 1H), 7.93 (d, J = 8.2 Hz, 
1H), 7.78 (d, J = 7.8 Hz, 1H), 7.51 – 7.41 (m, 3H), 7.40 – 7.35 (m, 3H), 7.32 (t, J = 7.6 Hz, 1H), 4.21 
(d, J = 3.5 Hz, 1H), 4.15 (d, J = 3.5 Hz, 1H), 3.02 (s, 3H); 13C NMR (100 MHz, CDCl3) δ175.3, 174.0, 
143.0, 134.6, 131.7, 131.5, 130.31, 130.26, 129.0, 128.7, 127.0, 125.91, 125.90, 124.2, 46.2, 45.6, 25.1; 
HRMS m/z calculated for [C21H15F3N2NaO3]






Prepared according to the General Procedure A using 2-(p-tolylethynyl)pyridine 6i (0.1 mmol, 1.0 
equiv.) and N-methylmaleimide 7a (1.5 equiv.), 16 mg, 53% yield; white solid; m.p. 171 – 173 °C; 1H 
NMR (400 MHz, CDCl3) δ 8.73 (ddd, J = 4.8, 1.8, 1.0 Hz, 1H), 8.42 (d, J = 8.3 Hz, 2H), 7.83 (dt, J = 
7.9, 1.1 Hz, 1H), 7.80 – 7.75 (m, 1H), 7.26 (d, J = 8.0 Hz, 2H), 7.23 (ddd, J = 7.4, 4.8, 1.3 Hz, 1H), 
4.19 (d, J = 3.7 Hz, 1H), 4.15 (d, J = 3.7 Hz, 1H), 2.97 (s, 3H), 2.40 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 175.2, 174.8, 151.7, 149.4, 143.7, 140.3, 136.6, 136.2, 129.7, 129.1, 122.9, 122.7, 44.6, 43.9, 
24.8, 21.6; HRMS m/z calculated for [C19H17N2O2]




Prepared according to the General Procedure A using 1,2-di(pyridin-2-yl)ethyne 6j (0.1 mmol, 1.0 
equiv.) and N-methylmaleimide 7a (1.5 equiv.), 15 mg, 51% yield; pale yellow solid; m.p. 212 – 214 °C; 
1H NMR (400 MHz, CDCl3) δ 8.77 – 8.76 (m, 2H), 8.61 (d, J = 7.9 Hz, 2H), 7.80 (td, J = 7.8, 1.9 Hz, 
2H), 7.29 – 7.26 (m, 2H), 4.33 (s, 2H), 2.97 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 174.6, 151.0, 149.7, 
142.2, 136.6, 124.8, 123.7, 44.4, 25.1; HRMS m/z calculated for [C17H13N3NaO2]
+ ([M+Na]+): 






Prepared according to the General Procedure A using 2-(pyridin-2-ylethynyl)pyrazine 6k (0.1 mmol, 
1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 15 mg, 51% yield; pale yellow solid; m.p. 222 – 
223 °C; 1H NMR (400 MHz, CDCl3) δ 10.23 (s, 1H), 8.79– 8.78 (m, 1H), 8.73 (m, 1H), 8.55– 8.53 (m, 
1H), 8.19 (d, J = 7.9 Hz, 1H), 7.84 (td, J = 7.8, 1.8 Hz, 1H), 7.32 (ddd, 7.6, 4.8. 1.1 Hz, 1H), 4.41 (d, J 
= 3.6 Hz, 1H), 4.30 (d, J = 3.6 Hz, 1H), 2.99 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 174.2, 173.9, 
150.6, 150.0, 147.0, 144.1, 143.9, 137.0, 132.2, 128.7, 124.4, 124.3, 121.6, 44.8, 44.1, 25.2; HRMS m/z 
calculated for [C16H13N4O2]




Prepared according to the General Procedure A using 1-(cyclopropylethynyl)-4-methylbenzene 6l (0.1 
mmol, 1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 18 mg, 67% yield; white solid; m.p. 98 – 
100 °C; 1H NMR (400 MHz, CDCl3) δ 7.53 (d, J = 8.2 Hz, 2H), 7.18 (d, J = 8.3 Hz, 2H), 3.89 (d, J = 
3.5, 1H), 3.50 (d, J = 3.5 Hz, 1H), 2.94 (s, 3H), 2.35 (s, 3H), 1.96 – 1.89 (m, 1H), 1.16 – 1.10 (m, 1H), 
1.00 – 0.80 (m, 3H) 13C NMR (100 MHz, CDCl3) δ 175.7, 175.5, 143.1, 138.8, 138.2, 130.5, 129.5, 
126.3, 43.8, 24.9, 21.5, 11.4, 6.8, 6.5; HRMS m/z calculated for [C17H18NO2]
+ ([M+H]+): 268.1332, 






Prepared according to the General Procedure A using 1,4-bis((4-chlorobenzyl)oxy)but-2-yne 6m (0.1 
mmol, 1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 25 mg, 56% yield; colorless oil; 1H NMR 
(400 MHz, CDCl3) δ 7.31 (d, J = 8.4 Hz, 4H), 7.24 (d, J = 8.3 Hz, 4H), 4.48 (s, 4H), 4.17 (d, J = 13.1 
Hz, 2H), 4.09 (d, J = 13.2 Hz, 2H), 3.73 (s, 2H), 2.95 (s, 3H) 13C NMR (100 MHz, CDCl3) δ 174.5, 
142.7, 136.2, 133.7, 129.1, 128.8, 72.5, 65.3, 45.4, 24.9; HRMS m/z calculated for [C23H21Cl2NNaO4]
+ 




Prepared according to the General Procedure A using but-2-yne-1,4-diol (0.1 mmol, 1.0 equiv.) 6n and 
N-methylmaleimide 7a (1.5 equiv.), 18 mg, 91% yield; colorless oil; 1H NMR (400 MHz, CDCl3) δ 
4.34 (s, 4H), 3.68 (s, 2H), 2.96 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 174.9, 142.5, 58.7, 44.7, 24.8; 
HRMS m/z calculated for [C9H11NNaO4]




Prepared according to the General Procedure A using benzyldimethyl(3-phenylprop-1-yn-1-yl)silane 
6o (0.1 mmol, 1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 27 mg, 72% yield; colorless oil; 1H 
NMR (400 MHz, CDCl3) δ 7.31 – 7.28 (m, 2H), 7.24 – 7.18 (m, 3H), 7.12 – 7.07 (m, 3H), 6.95 – 6.92 
(m, 2H), 3.61 (d, J = 3.2 Hz, 1H), 3.44 (d, J = 3.2 Hz, 1H), 3.26 (s, 2H), 2.96 (s, 3H), 2.22 (d, J = 2.6 
Hz, 2H), 0.23 (s, 3H), 0.19 (s, 3H) 13C NMR (100 MHz, CDCl3) δ 176.2, 174.7, 162.7, 146.6, 139.1, 
136.7, 129.0, 128.9, 128.4, 128.3, 126.8, 124.5, 48.8, 45.1, 37.5, 25.5, 24.8, -2.9, -3.0; HRMS m/z 
calculated for [C23H25NNaO2Si]







Prepared according to the General Procedure A using 1-((trimethylsilyl)ethynyl)cyclohexan-1-ol 6p 
(0.1 mmol, 1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 29 mg, 94% yield; white solid; m.p. 89 
– 91 °C; 1H NMR (400 MHz, CDCl3) δ 3.83 (d, J = 3.2 Hz, 1H), 3.48 (d, J = 3.2 Hz, 1H), 2.95 (s, 3H), 
1.72 – 1.49 (m, 9H), 1.30 – 1.16 (m, 1H), 0.21 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 175.9, 175.8, 
168.0, 146.2, 72.7, 47.1, 43.8, 36.4, 36.0, 25.2, 25.0, 21.24, 21.18, -0.4; HRMS m/z calculated for 
[C16H26NO3Si]




Prepared according to the General Procedure A using 1-ethynylcyclohexan-1-ol 6q (0.1 mmol, 1.0 
equiv.) and N-methylmaleimide 7a (1.5 equiv.), 14 mg, 60% yield; white solid; m.p. 120 – 122 °C; 1H 
NMR (400 MHz, CDCl3) δ 6.18 (d, J = 1.1 Hz, 1H), 3.85 (d, J = 3.2 Hz, 1H), 3.63 (dd, J = 3.2, 1.0 Hz, 
1H), 2.97 (s, 3H), 1.69 – 1.28 (m, 10H); 13C NMR (100 MHz, CDCl3) δ 175.6, 175.2, 158.3, 128.3, 
71.0, 46.4, 43.1, 35.9, 35.2, 25.4, 25.1, 21.8, 21.7; HRMS m/z calculated for [C13H18NO3]
+ ([M+H]+): 






Prepared according to the General Procedure A using N-(1-ethynylcyclohexyl)acetamide 6r (0.1 mmol, 
1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 27 mg, 98% yield; white solid; 1H NMR (400 MHz, 
CDCl3) δ 6.16 (d, J = 1.2 Hz, 1H), 5.48 (br s, 1 H), 3.71 (d, J = 3.2 Hz, 1H), 3.61 (dd, J = 3.2, 1.2 Hz, 
1H), 2.93 (s, 3H), 2.09 – 2.02 (m, 2H), 1.97 (s, 3H), 1.62 – 1.26 (m, 8H) 13C NMR (100 MHz, CDCl3) 
δ 175.5, 175.3, 169.8, 156.0, 128.7, 55.3, 46.7, 42.9, 33.4, 33.1, 25.3, 25.0, 24.1, 21.5, 21.4; HRMS m/z 
calculated for [C15H20N2NaO3]
+ ([M+Na]+): 299.1366, observed : 299.1366 
 
2-(3-cyclohexyl-2,4-dioxo-3-azabicyclo[3.2.0]hept-6-en-6-yl)-2-hydroxypropanoic acid (8si) 
 
Prepared according to the General Procedure A using 2-hydroxy-2-methylbut-3-ynoic acid 6s (0.1 
mmol, 1.0 equiv.) and 1-cyclohexyl-1H-pyrrole-2,5-dione 7i (1.5 equiv.), 25 mg, 85% yield (d.r. = 1.3:1); 
pale yellow solid; The NMR spectrum was obtained on a partially purified material as a mixture of 
diastereomers; 1H NMR (400 MHz, CD3OD) δ 6.31 (dd, J = 4.8, 1.1 Hz, 2H), 3.92 – 3.82 (m, 3H), 3.74 
(d, J = 3.2 Hz, 1H), 3.5 (ddd, J = 5.5, 3.2, 1.0 Hz, 2H), 2.16 – 2.01 (m, 4H), 1.84 – 1.81 (m, 4H), 1.68 
– 1.51 (m, 12H), 1.40 – 1.13 (m, 6H) 13C NMR (100 MHz, CD3OD) δ 177.8, 177.7, 177.5, 177.4, 177.11, 
177.07, 156.2, 155.7, 131.7, 131.5, 75.5, 72.6, 52.7, 52.7, 48.0, 47.6, 44.0, 44.0, 29.6, 29.5, 29.5, 27.02, 
27.00, 26.3, 24.6, 23.9; HRMS m/z calculated for [C15H19NNaO5]







Prepared according to the General Procedure A using (3r,5r,7r)-1-ethynyladamantane 6t (0.1 mmol, 
1.0 equiv.) and N-methylmaleimide 7a (1.5 equiv.), 13 mg, 48% yield; white solid; m.p. 138-139 °C; 
1H NMR (400 MHz, CDCl3) δ 5.97 (d, J = 0.9 Hz, 1H), 3.76 (d, J = 3.2 Hz, 1H), 3.55 (dd, J = 3.2, 1.1 
Hz, 1H), 2.95 (s, 3H), 2.00 (s, 3H), 1.77 – 1.62 (m, 12H).; 13C NMR (100 MHz, CDCl3) δ 175.9, 175.4, 
162.1, 125.8, 46.2, 43.1, 39.6, 36.5, 36.1, 27.8, 24.8; HRMS m/z calculated for [C17H22NO2]
+ ([M+H]+): 




Prepared according to the General Procedure A using 1-phenylbut-3-yn-1-ol 6u (0.1 mmol, 1.0 equiv.) 
and N-methylmaleimide 7a (1.5 equiv.), 20 mg, 78% yield (d.r. = 1:1); pale yellow solid; m.p. 104 – 
106 °C; The NMR spectrum was obtained on a partially purified material as a mixture of diastereomers; 
1H NMR (400 MHz, CDCl3) δ 7.35 – 7.34 (m, 6.13H), 7.31 – 7.28 (m, 1.28H), 6.17 (d, J = 1.4 Hz, 1H), 
6.14 (d, J = 1.4 Hz, 0.5H), 4.98 (dt, J = 7.9, 3.7 Hz, 1H), 4.89 (dt, J = 8.1, 3.9 Hz, 0.5H), 3.78 (d, J = 
3.0 Hz, 0.5H), 3.74 (d, J = 2.8 Hz, 1H), 3.64 (m, 1.5H), 3.01 (d, J = 3.7 Hz, 0.5H), 2.96 (s, 1.5H), 2.91 
(s, 3H), 2.73 – 2.57 (m, 3.4H), 2.39 (d, J = 4.1 Hz, 1H) 13C NMR (100 MHz, CDCl3) δ 175.8, 175.8, 
175.5, 175.4, 150.5, 150.5, 143.5, 143.5, 132.4, 132.2, 128.7, 128.7, 128.0, 128.0, 125.8, 125.8, 71.8, 
71.7, 49.2, 48.9, 44.7, 44.6, 39.9, 39.5, 25.0, 24.9; HRMS m/z calculated for [C15H15NNaO3]
+ ([M+Na]+): 






Prepared according to the General Procedure A using 1,4-di-p-tolylbuta-1,3-diyne 6v (0.1 mmol, 1.0 
equiv.) and N-methylmaleimide 7a (1.5 equiv.), 24 mg, 70% yield; white solid; m.p. 163 – 165 °C; 1H 
NMR (400 MHz, CDCl3) δ 7.78 (d, J =8.2 Hz, 2H), 7.43 (d, J = 8.1 Hz, 2H), 7.23 (d, J = 7.9 Hz, 2H), 
7.18 (d, J = 7.9 Hz, 2H), 4.08 (d, J = 3.6 Hz, 1H), 3.95 (d, J = 3.6 Hz, 1H), 2.98 (s, 3H), 2.38 (s, 6H); 
13C NMR (100 MHz, CDCl3) δ 174.2, 174.0, 148.6, 140.2, 139.5, 131.7, 129.6, 129.4, 129.2, 126.4, 
119.2, 118.0, 99.3, 82.5, 46.6, 45.4, 24.9, 21.6, 21.6; HRMS m/z calculated for [C23H20NO2]
+ ([M+H]+): 
342.1489, observed : 342.1490 
 
4-(benzylcarbamoyl)-2,3-di-p-tolylcyclobut-2-ene-1-carboxylic acid (8ab′) 
 
6,7-di-p-tolyl-3-oxabicyclo[3.2.0]hept-6-ene-2,4-dione 8ab was prepared according to the General 
Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) and maleic anhydride (1.5 equiv.), 
and used without further purification. To a solution of 6,7-di-p-tolyl-3-oxabicyclo[3.2.0]hept-6-ene-2,4-
dione 8ab (1.0 equiv.) in CH2Cl2 (1 mL) was added Et3N (0.2 mmol, 2.0 equiv.) and benzylamine (1.2 
equiv.). The solution was stirred for 1 h, and then the mixture was concentrated in vacuo. Column Flash 
chromatography separated the residue on silica gel to afford the desired product., 40 mg, 97% yield; 
white solid; m.p. 189 – 190 °C; 1H NMR (400 MHz, DMSO-d6) δ 12.09 (br s, 1H), 8.61 (t, J = 5.9 Hz, 
1H), 7.45 (d, J = 8.1 Hz, 2H), 7.32 – 7.24 (m, 7H), 7.17 (d, J = 8.0 Hz, 2H), 7.14 (d, J = 8.0 Hz, 2H), 
4.31 (dd, J = 5.9, 2.6 Hz, 2H), 4.12 – 4.09 (m, 2H), 2.31 (s, 3H), 2.30 (s, 3H) 13C NMR (100 MHz, 
DMSO-d6) δ 171.6, 169.7, 139.4, 137.8, 137.7, 137.5, 137.3, 131.5, 131.3, 129.0, 128.8, 128.2, 127.3, 
126.73, 126.71, 126.1, 48.1, 45.1, 42.3, 29.9, 20.9; HRMS m/z calculated for [C27H25NNaO3]
+ 






Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and (E)-1,4-di(pyrrolidin-1-yl)but-2-ene-1,4-dione 2c (1.5 equiv.), 27 mg, 63% yield; white solid; m.p. 
183 – 184 °C; 1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 8.1 Hz, 4H), 7.07 (d, J = 7.9 Hz, 4H), 4.21 
(s, 2H), 3.58 – 3.51 (m, 6H), 3.48 – 3.42 (m, 2H), 2.31 (s, 6H), 1.95 – 1.82 (m, 8H) 13C NMR (100 
MHz, CDCl3) δ 170.0, 139.3, 137.7, 131.8, 129.0, 126.5, 46.8, 46.5, 46.0, 26.2, 24.3, 21.4; HRMS m/z 
calculated for [C28H33N2O2]
+ ([M+H]+): 429.2537, observed : 429.2542; The stereochemistry was 




1H NMR (400 MHz, CDCl3) δ 7.34 (d, J = 8.1 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 7.15 (d, J = 7.8 Hz, 
2H), 7.08 (d, J = 7.9 Hz, 2H), 4.14 (d, J = 1.5 Hz, 1H), 3.98 (dt, J = 10.0, 6.6 Hz, 1H), 3.79 (dt, J = 
9.9, 2.0 Hz, 1H), 3.61 (dt, J = 10.0, 6.9 Hz, 1H), 3.53 (dt, J = 12.1, 7.1 Hz, 1H), 3.42 (ddd, J = 12.1, 
7.5, 6.0 Hz, 1H), 3.36 – 3.30 (m, 1H), 3.27 – 3.21 (m, 1H), 3.01 – 2.91 (m, 2H), 2.81 – 2.75 (m, 1H), 
2.73 – 2.66 (m, 1H), 2.36 (s, 3H), 2.32 (s, 3H), 2.21 – 2.16 (m, 2H), 1.95 – 1.74 (m, 6H); MS (APCI): 












Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and N1,N4-dimethyl-N1,N4-diphenylmaleamide 7d (1.5 equiv.), 27 mg, 54% yield; white solid; m.p. 167 
– 169 °C; 1H NMR (400 MHz, CDCl3) δ 7.49 – 7.29 (m, 6H), 7.19 – 6.99 (m, 12H), 3.96 (s, 2H), 3.20 
(s, 6H), 2.32 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 170.7, 143.4, 139.3, 137.7, 131.3, 129.7, 128.9, 
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128.0, 127.2, 126.6, 46.0, 37.9, 21.4; HRMS m/z calculated for [C34H32N2NaO2]
+ ([M+Na]+) : 523.2356, 




1H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 8.1 Hz, 4H), 7.28 – 7.24 (m, 2H), 7.15 – 7.11 (m, 4H), 6.79 
(d, J = 7.9 Hz, 2H), 6.73 (t, J = 7.3 Hz, 1H), 3.85 (dd, J = 11.1, 4.4 Hz, 1H), 3.71 – 3.64 (m, 2H), 3.41 
(dd, J = 14.7, 8.9 Hz, 1H), 3.31 (ddd, J = 8.8, 4.7, 1.5 Hz, 1H), 3.13 (ddd, J = 7.3, 4.3, 1.5 Hz, 1H), 
2.90 (s, 3H), 2.36 (s, 3H), 2.34 (s, 3H); MS (APCI): m/z 384.1 [M+H]+ 
 
Diethyl 3,4-di-p-tolylcyclobut-3-ene-1,2-dicarboxylate (8ae) 
 
Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and Diethyl fumarate 7e (1.5 equiv.), 19 mg, 51% yield; white solid; m.p. 91 – 93 °C; 1H NMR (400 
MHz, CDCl3) δ 7.43 (d, J = 8.2 Hz, 4H), 7.12 (d, J = 7.9 Hz, 4H), 4.18 – 4.08 (m, 6H), 2.35 (s, 6H), 
1.19 (t, J = 7.1 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 171.5, 138.3, 138.0, 130.6, 129.0, 126.6, 60.9, 
45.9, 21.4, 14.1; HRMS m/z calculated for [C24H27O4]




Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and fumaronitrile (1.5 equiv.), 16 mg, 51% yield, (cis/trans 1.3:1); (cis-8vf): yellow solid; m.p. 163 – 
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164 °C; 1H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.1 Hz, 2H), 7.45 (d, J = 8.1 Hz, 2H), 7.27 (d, J = 
8.1 Hz, 2H), 7.21 (d, J = 7.9 Hz, 2H), 4.23 (d, J = 5.1 Hz, 1H), 4.17 (d, J = 5.1 Hz, 1H), 2.41 (s, 3H), 
2.40 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 143.8, 141.5, 140.3, 131.9, 129.7, 129.4, 127.8, 125.9, 
118.2, 115.2, 115.1, 114.7, 99.8, 81.0, 33.9, 31.3, 21.71, 21.67; HRMS m/z calculated for [C22H16N2Na
]+ 
([M+Na]+): 331.1206, observed 331.1206; (trans-8vf): yellow solid; m.p. 57 – 58 °C; 1H NMR (400 
MHz, CDCl3); δ 7.61 (d, J = 8.1 Hz, 2H), 7.45 (d, J = 8.1 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 7.21 (d, J 
= 7.9 Hz, 2H), 4.11 (d, J = 2.4 Hz, 1H), 4.07 (d, J = 2.3 Hz, 1H), 2.41 (s, 3H), 2.40 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ 143.6, 141.6, 140.4, 131.9, 129.8, 129.4, 127.7, 125.9, 118.2, 115.92, 115.90, 
114.7, 99.9, 80.9, 34.1, 31.4, 21.71, 21.67; HRMS m/z calculated for [C22H16N2Na]
+ ([M+Na]+): 
331.1206, observed 331.1206. 
 
Methyl 4-(ethyl(p-tolyl)carbamoyl)-2,3-diphenylcyclobut-2-ene-1-carboxylate (8cg) 
 
Prepared according to the General Procedure A using 1,2-diphenylethyne 6c (0.1 mmol, 1.0 equiv.) 
and methyl (Z)-4-(ethyl(p-tolyl)amino)-4-oxobut-2-enoate 7g (1.5 equiv.), 18 mg, 42% yield (cis/trans 
1:5); white solid; (cis-8cg): 1H NMR (400 MHz, CDCl3) δ 7.52 – 7.49 (m, 2H), 7.41 – 7.38 (m, 2H), 
7.31 – 7.22 (m, 10H), 4.07 – 4.02 (m, 2H), 3.86 (d, J = 5.5 Hz, 1H), 3.72 (s, 3H), 3.53 – 3.45 (m, 1H), 
2.40 (s, 3H), 1.12 (t, J = 7.1 Hz, 3H) 13C NMR (100 MHz, CDCl3) δ 171.5, 169.3, 140.0, 139.7, 138.1, 
138.0, 134.3, 134.2, 130.5, 128.5, 128.39, 128.35, 128.3, 128.2, 127.1, 126.8, 52.1, 46.9, 45.9, 44.7, 
21.2, 13.1; HRMS m/z calculated for [C28H27NNaO3]
+ ([M+Na]+): 448.1883, observed : 448.1884; 
(trans-8cg): 1H NMR (400 MHz, CDCl3) δ 7.45 – 7.41 (m, 4H), 7.34 – 7.22 (m, 8H), 7.08 (d, J = 8.1 
Hz, 2H), 3.95 (d, J = 2.0 Hz, 1H), 3.93 (d, J = 2.1 Hz, 1H), 3.83 (dq, J = 14.2, 7.1 Hz, 1H), 3.66 (dq, 
J = 14.2, 7.1 Hz, 1H), 3.50 (s, 3H), 2.39 (s, 3H), 1.10 (t, J = 7.1 Hz, 3H) 13C NMR (100 MHz, CDCl3) 
δ 171.9, 170.1, 140.4, 139.1, 138.2, 138.1, 134.2, 133.6, 130.4, 128.5, 128.44, 128.42, 128.38, 128.36, 
126.8, 126.5, 51.9, 47.5, 45.1, 44.4, 21.2, 13.2; HRMS m/z calculated for [C28H27NNaO3]
+ ([M+Na]+): 






Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and maleimide 7h (1.5 equiv.), 25 mg, 82% yield; white solid; m.p. 227 – 229 °C; 1H NMR (400 MHz, 
CDCl3) δ 7.62 (d, J = 8.2 Hz, 4H), 7.58 (br s, 1H), 7.19 (d, J = 8.0 Hz, 4H), 4.08 (d, J = 1.0 Hz, 2H), 
2.37 (s, 6H) 13C NMR (100 MHz, CDCl3) δ 175.4, 139.4, 138.1, 130.3, 129.5, 126.9, 46.4, 21.6; HRMS 
m/z calculated for [C20H18NO2]




Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and 1-cyclohexyl-1H-pyrrole-2,5-dione 7i (1.5 equiv.), 31 mg, 80% yield; white solid; m.p. 178 – 
180 °C; 1H NMR (400 MHz, CDCl3) δ 7.63 (d, J = 8.1 Hz, 4H), 7.17 (d, J = 8.0 Hz, 4H), 3.97 (s, 2H), 
3.91 (tt, J = 12.3, 3.9 Hz, 1H), 2.36 (s, 6H), 2.15 – 2.00 (m, 2H), 1.85 – 1.75 (m, 2H), 1.68 – 1.56 (m, 
2H), 1.36 – 1.11 (m, 4H) 13C NMR (100 MHz, CDCl3) δ 175.5, 139.2, 138.8, 130.5, 129.4, 126.9, 51.6, 
44.6, 28.7, 26.0, 25.2, 21.6; HRMS m/z calculated for [C26H28NO2]





Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and 1-(benzyloxy)-1H-pyrrole-2,5-dione 7j (1.5 equiv.), 17 mg, 42% yield; white solid; m.p. 167 – 
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169 °C; 1H NMR (400 MHz, CDCl3) δ 7.56 (d, J = 8.2 Hz, 4H), 7.39 – 7.36 (m, 2H), 7.21 – 7.17 (m, 
7H), 5.07 (s, 2H), 3.97 (s, 2H), 2.38 (s, 6H) 13C NMR (100 MHz, CDCl3) δ 170.3, 139.5, 138.1, 133.3, 
130.2, 130.1, 129.42, 129.36, 128.5, 126.9, 78.4, 42.2, 21.6; HRMS m/z calculated for [C27H23NNaO3]
+ 




Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzonitrile 7k (1.5 equiv.), 24 mg, 59% yield; white 
solid; m.p. 214 – 215 °C; 1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 8.9 Hz, 2H), 7.67 (d, J = 8.2 Hz, 
4H), 7.47 (d, J = 8.9 Hz, 2H), 7.20 (d, J = 7.9 Hz, 4H), 4.24 (s, 2H), 2.38 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 173.2, 139.6, 138.1, 135.9, 129.9, 129.4, 127.0, 126.8, 118.1, 111.9, 44.8, 21.5; HRMS m/z 
calculated for [C27H21N2O2]
+ ([M+H]+): 405.1598, observed : 405.1612 
 
Methyl 4-(2,4-dioxo-6,7-di-p-tolyl-3-azabicyclo[3.2.0]hept-6-en-3-yl)benzoate (8al) 
 
Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and methyl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate 7l (1.5 equiv.), 20 mg, 46% yield; white 
solid; m.p. 227 – 229 °C; 1H NMR (400 MHz, CDCl3) δ 8.09 (d, J = 8.5 Hz, 2H), 7.68 (d, J = 8.3, 4H), 
7.39 (d, J = 8.5 Hz, 2H), 7.20 (d, J = 8.4 Hz, 4H), 4.23 (s, 2H), 3.91 (s, 3H), 2.38 (s, 6H) 13C NMR 
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(100 MHz, CDCl3) δ 173.7, 166.4, 139.6, 138.4, 136.2, 130.4, 130.2, 129.9, 129.5, 127.0, 126.5, 52.4, 
45.0, 21.6; HRMS m/z calculated for [C28H24NO4]




Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and 1-phenyl-1H-pyrrole-2,5-dione 7m (1.5 equiv.), 11 mg, 29% yield; white solid; m.p. 185 – 187 °C; 
1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 8.1 Hz, 4H), 7.44 – 7.40 (m, 2H), 7.36 – 7.32 (m, 1H), 7.27 
– 7.24 (m, 2H), 7.19 (d, J = 7.9 Hz, 4H), 4.21 (s, 2H), 2.37 (s, 6H) 13C NMR (100 MHz, CDCl3) δ 174.2, 
139.5, 138.5, 132.1, 130.4, 129.5, 129.1, 128.6, 127.0, 126.7, 45.1, 21.6; HRMS m/z calculated for 
[C26H22NO2]




Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and 1-(pyridin-3-yl)-1H-pyrrole-2,5-dione 7n (1.5 equiv.), 21 mg, 55% yield; white solid; m.p. 195 – 
196 °C; 1H NMR (400 MHz, CDCl3) δ 8.60 – 8.58 (m, 2H), 7.68 (d, J = 8.3 Hz, 4H), 7.66 – 7.63 (m, 
1H), 7.36 (dd, J = 8.2, 4.8 Hz, 1H), 7.20 (d, J = 8.3 Hz, 4H), 4.25 (s, 2H), 2.38 (s, 6H) 13C NMR (100 
MHz, CDCl3) δ 173.7, 149.3, 147.6, 139.7, 138.3, 134.0, 130.1, 129.5, 128.1, 127.0, 123.6, 45.1, 21.6; 
HRMS m/z calculated for [C25H21N2O2]






Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and 3-bromo-1-methyl-1H-pyrrole-2,5-dione 7o (1.5 equiv.), 37 mg, 93% yield; pale yellow solid; m.p. 
214 – 215 °C; 1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 8.2 Hz, 2H), 7.63 (d, J = 8.2 Hz, 2H), 7.24 
(d, J = 8.0 Hz, 2H), 7.20 (d, J = 7.9 Hz, 2H), 4.30 (s, 1H), 3.01 (s, 3H), 2.40 (s, 3H), 2.37 (s, 3H) 13C 
NMR (100 MHz, CD2Cl2) δ 172.9, 172.2, 141.4, 140.7, 138.9, 138.7, 130.00, 129.95, 129.4, 128.4, 
128.2, 128.0, 56.0, 52.0, 25.8, 21.9, 21.8; HRMS m/z calculated for [C21H18BrNNaO2]
+ ([M+Na]+): 




Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and 3-methoxy-1-methyl-1H-pyrrole-2,5-dione 7p (1.5 equiv.), 34 mg, 98% yield; white solid; m.p. 152 
– 154 °C; 1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 8.2 Hz, 2H), 7.66 (d, J = 8.2 Hz, 2H), 7.20 (d, J 
= 8.2 Hz, 4H), 4.11 (s, 1H), 3.42 (s, 3H), 2.99 (s, 3H), 2.37 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 
174.0, 173.5, 140.1, 139.4, 139.3, 138.7, 129.4, 129.4, 129.3, 128.9, 127.3, 127.1, 81.7, 53.4, 49.1, 24.7, 
21.49, 21.48; HRMS m/z calculated for [C22H22NO3]




Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and 1,3-dimethyl-1H-pyrrole-2,5-dione 7q (1.5 equiv.), 29 mg, 88% yield; white solid; m.p. 182 – 
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183 °C; 1H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 8.2 Hz, 2H), 7.58 (d, J = 8.2 Hz, 2H), 7.18 (d, J = 
7.9 Hz, 2H), 7.16 (d, J = 7.9 Hz, 2H), 3.78 (s, 1H), 2.97 (s, 3H), 2.37 (s, 3H), 2.35 (s, 3H), 1.63 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ 178.7, 175.0, 142.1, 139.3, 139.1, 137.2, 130.0, 129.9, 129.5, 129.4, 
127.3, 126.9, 51.6, 50.9, 29.8, 25.0, 21.6, 15.8; HRMS m/z calculated for [C22H21NNaO2]
+ ([M+Na]+): 




Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and 3-methyl-1-phenyl-1H-pyrrole-2,5-dione 7r (1.5 equiv.), 39 mg, 99% yield; white solid; m.p. 210 
– 211 °C; 1H NMR (400 MHz, CDCl3) δ 7.65 (t, J = 8.0 Hz, 4H), 7.47 – 7.31 (m, 3H), 7.27 (d, J = 8.6 
Hz, 2H), 7.23 – 7.14 (m, 4H), 3.94 (s, 1H), 2.39 (s, 3H), 2.37 (s, 3H), 1.74 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 177.4, 173.6, 142.1, 139.3, 139.0, 137.2, 132.1, 129.8, 129.7, 129.4, 129.3, 128.9, 128.3, 
127.3, 126.9, 126.6, 51.3, 50.6, 21.48, 21.47, 15.8; HRMS m/z calculated for [C27H24NO2]
+ ([M+H]+): 




Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and 1,3,4-trimethyl-1H-pyrrole-2,5-dione 7s (1.5 equiv.), 19 mg, 55% yield; white solid; m.p. 180 – 
181 °C; 1H NMR (400 MHz, CDCl3) δ 7.54 (d, J = 8.2 Hz, 4H), 7.14 (d, J = 7.9 Hz, 4H), 2.97 (s, 3H), 
2.35 (s, 6H), 1.58 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 178.5, 142.1, 138.8, 129.7, 129.3, 127.2, 54.3, 
24.8, 21.4, 13.3; HRMS m/z calculated for [C23H24NO2]







Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and (S,Z)-4-((1-methoxy-1-oxopropan-2-yl)amino)-4-oxobut-2-enoic acid 7t (1.5 equiv.), 38 mg, 93% 
yield (cis/trans 4.4:1); The NMR spectrum was obtained on a partially purified material as a mixture of 
diastereomers; (cis-8at) (d.r. 1:1) : white solid; m.p. 168 – 169 °C; 1H NMR (400 MHz, DMSO-d6) δ 
8.63 (d, J = 6.9 Hz, 0.5H), 8.50 (d, J = 7.7 Hz, 0.5H), 7.44 – 7.27 (m, 4H), 7.19 – 7.10 (m, 4H), 4.29 
(td, J = 7.3, 5.4 Hz, 1H), 4.11 – 4.01 (m, 2H), 3.61 (s, 1.5H), 3.59 (s, 1.5H), 2.29 (s, 3H), 2.28 (s, 3H), 
1.29 (d, J = 7.3 Hz, 1.5H), 1.25 (d, J = 7.1 Hz, 1.5H); 13C NMR (100 MHz, DMSO-d6) δ 173.5, 173.1, 
171.8, 171.7, 170.1, 169.7, 138.4, 138.2, 138.12, 138.07, 137.8, 137.7, 137.6, 137.4, 131.92, 131.86, 
131.60, 131.57, 129.5, 129.4, 129.22, 129.20, 127.2, 127.1, 126.48, 126.45, 52.3, 52.2, 48.11, 48.02, 
47.97, 47.9, 45.5, 45.4, 21.4, 21.3, 17.8, 17.5.; HRMS m/z calculated for [C24H25NNaO5]
+ ([M+Na]+) : 
430.1625, observed 430.1626; (trans-8at) (d.r. 1.5:1) : white solid; m.p. 190 – 192 °C; 1H NMR (400 
MHz, DMSO-d6) δ 8.75 (t, J = 8.7 Hz, 1H), 7.42-7.36 (m, 4H), 7.19 (t, J = 7.5 Hz, 4H), 4.29 (dp, J = 
14.5, 7.2 Hz, 1H), 3.98 (d, J = 1.9 Hz, 0.6H), 3.91 (d, J = 1.8 Hz, 0.4H), 3.77 (d, J = 1.8 Hz, 0.6H), 
3.72 (d, J = 1.8 Hz, 0.4H), 3.61 (s, 1.8H), 3.52 (s, 1.2H), 2.31 (s, 3.6H), 2.30 (s, 2.4H), 1.31 (d, J = 7.3 
Hz, 1.2H), 1.24 (d, J = 7.2 Hz, 1.8H) 13C NMR (100 MHz, DMSO-d6) δ 173.5, 173.4, 173.35, 173.26, 
170.4, 170.3, 138.83, 138.80, 138.4, 138.33, 138.33, 138.30, 138.0, 137.9, 131.3, 131.15, 131.13, 
131.13, 129.6, 129.6, 129.5, 129.4, 126.53, 126.49, 126.46, 126.4, 52.3, 52.2, 48.2, 48.0, 46.8, 46.7, 
46.0, 45.6, 40.6, 21.39, 21.38, 17.6, 17.4; HRMS m/z calculated for [C24H25NNaO5]
+ ([M+Na]+) : 




Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and 1-methyl-3-(p-tolyl)-1,5-dihydro-2H-pyrrol-2-one 7v (1.5 equiv.), 17 mg, 43% yield; white solid; 
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m.p. 170 – 171 °C; 1H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 8.2 Hz, 2H), 7.45 (d, J = 8.1 Hz, 2H), 
7.20 (d, J = 8.1 Hz, 2H), 7.17 (d, J = 7.9 Hz, 2H), 7.08 – 7.05 (m, 4H), 3.60 (dd, J = 10.2, 8.2 Hz, 1H), 
3.50 (dd, J = 8.2, 1.6 Hz, 1H), 3.30 (dd, J = 10.2, 1.7 Hz, 1H), 2.38 (s, 3H), 2.30 (s, 3H), 2.28 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 174.2, 143.0, 139.8, 138.6, 138.1, 136.5, 135.5, 130.6, 130.5, 129.5, 
129.3, 129.2, 127.8, 127.4, 126.9, 59.0, 48.4, 45.8, 30.8, 21.58, 21.57, 21.2; HRMS m/z calculated for 
[C28H28NO]




Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and coumarin 7w (1.5 equiv.), 25 mg, 71% yield; white solid; m.p. 183 – 184 °C; 1H NMR (400 MHz, 
CDCl3) δ 7.60 (d, J = 8.2 Hz, 2H), 7.30 (d, J = 8.1 Hz, 2H), 7.23 – 7.18 (m, 2H), 7.14 (d, J = 8.0 Hz, 
2H), 7.11 (d, J = 8.0 Hz, 2H), 7.05 – 7.01 (m, 2H), 4.45 (d, J = 4.6 Hz, 1H), 4.35 (d, J = 4.6 Hz, 1H), 
2.34 (s, 3H), 2.32 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 168.0, 151.1, 144.2, 138.8, 138.6, 136.3, 
131.2, 130.4, 129.4, 129.2, 129.1, 128.5, 127.4, 126.8, 124.4, 121.6, 117.6, 42.8, 41.8, 21.5; HRMS m/z 
calculated for [C25H21O2]





Prepared according to the General Procedure A using tert-butyldimethyl(2-(p-
tolylethynyl)phenoxy)silane 6w (0.1 mmol, 1.0 equiv.) and coumarin 7w (1.5 equiv.), 27 mg, 58% yield; 
white solid; m.p. 51 – 52 °C; 1H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 8.2 Hz, 2H), 7.23 – 7.13 (m, 
3H), 7.08 – 7.06 (m, 2H), 7.03 – 7.01 (m, 2H), 6.96 – 6.87 (m, 3H), 4.59 (d, J = 4.6 Hz, 1H), 4.38 (d, J 
= 4.6 Hz, 1H), 2.31 (s, 3H), 0.80 (s, 9H), 0.09 (s, 3H), -0.08 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
168.1, 153.6, 150.7, 142.4, 138.5, 137.2, 130.8, 130.1, 129.7, 129.0, 128.4, 128.2, 126.8, 125.9, 124.5, 
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121.7, 121.4, 120.3, 117.3, 42.6, 42.1, 25.7, 21.5, 18.2, -4.0, -4.6; HRMS m/z calculated for 
[C30H33O3Si]





Prepared according to the General Procedure A using tert-butyldimethyl(2-(p-
tolylethynyl)phenoxy)silane 6w (0.1 mmol, 1.0 equiv.) and coumarin 7w (1.5 equiv.), 15 mg, 32% yield; 
white solid; m.p. 148 – 149 °C; 1H NMR (400 MHz, CDCl3) δ 7.52 (dd, J = 7.5, 1.7 Hz, 1H), 7.33 (dd, 
J = 7.6, 1.8 Hz, 1H), 7.28 (d, J = 8.2 Hz, 2H), 7.25 – 7.20 (m, 2H), 7.13 (td, J = 7.5, 1.3 Hz, 1H), 7.06 
– 7.03 (m, 3H), 6.98 (td, J = 7.5, 1.1 Hz, 1H), 6.87 (dd, J = 8.3, 1.1 Hz, 1H), 4.51 (d, J = 4.5 Hz, 1H), 
4.39 (d, J = 4.5 Hz, 1H), 2.28 (s, 3H), 0.74 (s, 9H), 0.09 (s, 3H), 0.01 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 167.2, 153.8, 151.6, 145.7, 138.5, 135.2, 131.1, 130.3, 129.83, 129.79, 129.0, 128.6, 126.9, 
125.4, 124.4, 122.0, 121.3, 119.8, 118.0, 44.6, 41.3, 25.6, 21.5, 18.2, -4.0, -4.5; HRMS m/z calculated 
for [C30H33O3Si]




Prepared according to the General Procedure A using 2-(phenylethynyl)aniline 6x (0.1 mmol, 1.0 
equiv.) and coumarin 7w (1.5 equiv.), 23 mg, 68% yield; white solid; m.p. 88 – 89 °C; 1H NMR (400 
MHz, CDCl3) δ 7.61 – 7.59 (m, 2H), 7.34 – 7.28 (m, 3H), 7.23 – 7.19 (m, 1H), 7.17 – 7.13 (m, 1H), 
7.10 – 7.04 (m, 3H), 7.03 – 6.99 (m, 1H), 6.75 (td, J = 7.5, 1.1 Hz, 1H), 6.68 (dd, J = 8.1, 1.1 Hz, 1H), 
4.52 (d, J = 4.7 Hz, 1H), 4.50 (d, J = 4.6 Hz, 1H), 3.66 (br s, 2H); 13C NMR (100 MHz, CDCl3) δ 167.8, 
150.7, 143.9, 142.9, 137.9, 132.9, 129.8, 128.9, 128.8, 128.8, 128.6, 128.5, 127.1, 124.6, 121.2, 119.3, 
118.1, 117.5, 115.8, 42.6, 42.5; HRMS m/z calculated for [C23H18NO2]







Prepared according to the General Procedure A using di(p-tolyl)acetylene 6a (0.1 mmol, 1.0 equiv.) 
and 4-methylumbelliferone 7x (1.5 equiv.), 29 mg, 76% yield; white solid; m.p. 236 – 237 °C; 1H NMR 
(400 MHz, CDCl3) δ 7.43 (d, J = 8.2 Hz, 2H), 7.15 – 7.06 (m, 7H), 6.70 (d, J = 2.5 Hz, 1H), 6.61 (dd, 
J = 8.5, 2.6 Hz, 1H), 3.98 (s, 1H), 2.36 (s, 3H), 2.30 (s, 3H), 1.71 (s, 3H); 13C NMR (100 MHz, CDCl3) 
δ 168.9, 156.0, 150.7, 149.0, 138.6, 138.4, 134.7, 131.0, 130.1, 129.4, 129.2, 128.2, 127.5, 126.7, 117.8, 
112.1, 104.6, 50.4, 46.3, 24.1, 21.55, 21.52; HRMS m/z calculated for [C26H23O3]
+ ([M+H]+): 383.1642, 
observed : 383.1644. 
 
(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-17-(3-methyl-2,4-dioxo-3-azabicyclo[3.2.0]hept-6-
en-6-yl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl acetate (8ya) 
 
Prepared according to the General Procedure A using 17α-ethynylestradiol 3-acetate 6y (0.1 mmol, 1.0 
equiv.) and N-methylmaleimide 7a (1.5 equiv.), 30 mg, 66% yield (d.r. 1.4:1); yellow viscous oil; The 
NMR spectrum was obtained on a partially purified material as a mixture of diastereomers; 1H NMR 
(400 MHz, CDCl3) δ 7.23 (t, J = 7.7 Hz, 1H), 6.83 (d, J = 8.5 Hz, 1H), 6.79 (s, 0.6H), 6.79 (s, 0.4H), 
6.19 (d, J = 1.0 Hz, 0.6H), 6.18 (d, J = 1.0 Hz, 0.4H), 3.98 (d, J = 3.2 Hz, 0.4H), 3.87 (d, J = 3.2 Hz, 
0.6H), 3.73 (dd, J = 3.2, 0.9 Hz, 0.6H), 3.65 (dd, J = 3.2, 0.9 Hz, 0.4H), 2.99 (s, 1.8H), 2.98 (s, 1.2H), 
2.91 – 2.82 (m, 2H), 2.72 (s, 0.4H), 2.49 (s, 0.6H), 2.38 – 2.20 (m, 4H), 2.22 – 2.09 (m, 2H), 2.05 – 
1.82 (m, 4H), 1.64 – 1.46 (m, 5H), 1.42 – 1.27 (m, 3H), 0.95 (s, 1.8H), 0.92 (s, 1.2H); 13C NMR (100 
MHz, CDCl3) δ 176.05, 175.08, 175.07, 174.8, 169.83, 169.80, 158.7, 157.4, 148.46, 148.46, 138.14, 
138.14, 137.6, 137.5, 130.4, 128.5, 126.25, 126.25, 121.52, 121.51, 118.59, 118.58, 84.2, 84.0, 49.7, 
48.9, 48.8, 47.75, 47.70, 43.68, 43.65, 42.74, 42.66, 41.4, 39.0, 38.9, 37.5, 36.4, 33.5, 32.0, 29.5, 29.4, 
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28.2, 27.2, 27.2, 26.1, 26.0, 25.1, 24.8, 23.2, 23.1, 21.1, 14.1, 13.6.; HRMS m/z calculated for 
[C27H32NO5]





Prepared according to the General Procedure A using Efavirenz 6z (0.1 mmol, 1.0 equiv.) and N-
methylmaleimide 7a (15.0 equiv.), 19 mg, 45% yield (d.r. = 2.3:1); yellow viscous oil; The NMR 
spectrum was obtained on a partially purified material as a mixture of diastereomers; 1H NMR (400 
MHz, CDCl3) δ 9.28 (s, 1H), 7.39 – 7.35 (m, 1.3H), 7.34 (d, J = 2.2 Hz, 0.3H), 7.29 (s, 0.3H), 6.89 (dd, 
J = 8.5, 1.3 Hz, 0.3H), 6.85 (d, J = 8.4 Hz, 0.7H), 3.69 (d, J = 3.4 Hz, 0.7H), 3.56 (d, J = 3.5 Hz, 0.3H), 
3.48 (d, J = 3.4 Hz, 0.3H), 3.45 (d, J = 3.4 Hz, 0.7H), 2.92 (s, 0.9H), 2.90 (s, 2.1H), 1.82 – 1.66 (m, 
2H), 1.34 – 1.20 (m, 1H), 1.05 – 0.80 (m, 3H) ; 13C NMR (100 MHz, CDCl3) 173.6, 173.2, 173.2, 173.0, 
155.3, 154.3, 148.5, 148.3, 134.1, 133.9, 131.6, 131.5, 130.9, 130.4, 129.2, 128.9, 126.8, 126.6, 116.7, 
116.6, 114.1, 114.0, 77.3, 77.2, 43.7, 43.6, 43.0, 42.9, 25.1, 24.9, 10.8, 10.6, 7.9, 7.6, 7.0, 6.9.; HRMS 
m/z calculated for [C19H14ClF3N2NaO4]
+ ([M+Na]+): 449.0486, observed 449.0485. 
 
 
















Visible Light-promoted Enyne Photometathesis 





3.1. Ring Closing Enyne Metathesis 
 
 
Figure 3-1. Enyne metathesis 
 
Enyne metathesis is a variation of olefin metathesis reaction occur between alkenes and alkynes with a 
metal carbenoid complex as a catalyst producing a butadiene (Figure 3-1). In other sentence, it contains 
the combination of alkenes and alkynes to afford a corresponding 1,3-diene. Enyne metathesis is a 
powerful approach for the synthesis of highly stereoselective 1,3-diene systems under mild conditions 
by employing simpler substrate. The fact that not only to being a means to an end in itself, but also the 
1,3-diene so formed are themselves various synthetic intermediates that can proceed further selective 
transformations enhances the synthetic value of this reaction. In addition, enyne metathesis can give 
complete atom economy, that possesses olefin-side-product is not produced upon reaction. It means that 
the reaction is driven by enthalpic factors, the stability of the 1,3-diene so produced principally. Also, 
any several independent mechanisms can achieve enyne metathesis during the process of the reaction. 
Even if the net result is identical usually, the reaction is dictated by whether the transition metal complex 
or metal carbene species operate the process. The ring closing enyne metathesis is an intramolecular 
version, which is an efficient method for the formation of both heterocyclic and carbocyclic ring. In 
1985, Katz group developed enyne metathesis of diphenyl enyne to afford phenanthrene at the first 
(Scheme 3-1).45 Phenanthrene 18 can be prepared when using the carbene, which is a tungsten carbonyl 
group, in the reaction as stoichiometric amounts. And phenanthrene 20 can be obtained when using as 
catalytic amounts. When a metal atom is solely added on to alkyne carbon initially during the reaction, 




Scheme 3-1. First enyne metathesis by Katz et al. 
 
Mori et al. found out that Grubbs catalyst is effective for enyne metathesis in 1994.46 They demonstrated 
its applicability to the formation of five-, six-, and seven-membered nitrogen-containing heterocyclic 
rings. Inspired by this achievement, there are many approaches discovered for synthesis of 1,3-diene 
using Ru catalysts. It is well-known that Ru-based Grubbs catalysts undergo a highly selective α-
addition to alkynes to promote exo-cyclization during ring-closing enyne metathesis or to produce 
conjugated polyenes containing five-membered rings during the cyclopolymerization of 1,6-
heptadiynes. In 2016, Choi group reported the first example of β-selective addition to alkynes using 
Grubbs Z-selective catalyst, which produces only endo products during the ring-closing enyne 
metathesis reaction of terminal enynes and promoted the cyclopolymerization of 1,6-heptadiyne 
derivatives to give conjugated polyenes containing a six-membered ring as a major repeat unit (Scheme 
3-2).47 Not only Ru catalysts but also various transition metal catalysts have been utilized for ring 
closing enyne metathesis. PtCl2 also constituted an efficient and practical catalyst for ring closing enyne 
metathesis producing conjugated diene.48 In addition, the method includes a set of different 
rearrangement of enyne with atom economy. If not-saturated ethers are used, they accomplished the 
synthesis for polycycles bearing cyclopropane and also unexpected O – C allyl migration. Echavarren 
et al. reported theoretical and experimental studies that enlighten the complicated mechanistic problems 
using gold catalyst.49 This work strongly suggests that cyclobutene intermediates are not necessary in 
the skeletal rearrangement of enynes. Chatani group demonstrated that Rh(II) complexes are also active 
in the skeletal reorganization of 1,6- and 1,7-enynes to 1-vinylcycloalkenes.50 A characteristic feature 
of the Rh(II)-catalyzed skeletal reorganization of enynes is the wide applicability of enynes having a 
substituent, such as an alkyl, aryl, chloro, and ester substituent at the alkyne carbon. Most importantly, 
two possible isomers of 1-vinylcycloalkenes can be obtained, the ratio of which are significantly 
depending on the pattern of substituents of the enynes. 
The reaction mechanism of ring closing enyne metathesis can be classified by two pathways (Figure 3-
2). Exo- and endo-pathway can decide the structure depending on which carbon of alkyne metal catalyst 
binds with. If the metal coordinates selectively to the alkyne 21 in exo-pathway, cyclopropyl-metal 
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carbenes 22 are initially formed, which can react with alcohols or water to give products of alkoxy- or 
hydroxycyclization, whereas in the absence of nucleophiles, skeletal rearrangement forms dienes 23 
 
Scheme 3-2. Transition metal-catalyzed enyne metathesis 
 
and/or 24. Alternatively, coordination of MXn to the alkyne and the alkene is followed by oxidative 
cyclometallation to form 5-membered bicyclic intermediate 26, which usually evolves by β-hydrogen 
elimination to give Alder-ene-type products. Formation of products 23 could also occur by conrotatory 





Figure 3-2. General pathways of ring closing enyne metathesis 
 
pathway for the formation of 23 via ring-opening of 27 is favored by most chemists. However, the 
formation of dienes 24 requires a different mechanistic rationalization. Because ring closing enyne 
metathesis is useful method for the formation of cyclic compounds, it has been well utilized in total 
synthesis.51 Several stylish and informative applications of the enyne metathesis. Mori group has 
developed the ruthenium carbenoid catalyzed enyne metathesis. They reported the first total synthesis, 
which achieved an enyne metathesis for the synthesis of tricyclic alkaloid (-)-stemoamide in 1996 
(Scheme 3-3).52 This reaction is even more remarkable comparing to previous work by chemists on the 
ring closing enyne metathesis of alkyne moieties with carboalkoxy groups. 
 
 





Scheme 3-4. Total synthesis of (-)-longithorone A 
 
In other words, the intramolecular cyclization is promoted by the ester group, while the obtained 
unstable cross-conjugated compound generally proceeds further decomposition during isolation and is 
separated only in low yields. To account for the obvious discrepancy in the outstanding consequence, it 
was suggested that the conjugated diene is compelled to take up on a non-planar form in which the 
junction between the alkene π-systems is reduced by a steric hindrance, thus defending the system from 
destruction expected to occur in other ways. A few more steps were needed to synthesize target-product 
after enyne metathesis. The regiochemical result of macrocyclizations using enyne metathesis surely 
promoted for Shair et al. to attain the synthesis for (-)-longithorone A (Scheme 3-4).53 Enyne metathesis 
applied to the macrocycle formation at the first time, which had usually afforded the 1,2-disubstituted 
cycloadduct. They suggested to use an elegant sequence of both intra- and intermolecular Diels-Alder 
reactions to construct these noteworthy natural products. 
The enyne metathesis can be well established for cascade reactions to afford polycycles from simple 
substrates. A ring closing enyne metathesis first provides a fresh metal carbenoid which can be possibly 
blocked by another properly sited alkene in the same compound, achieving a next enyne metathesis to 
synthesize another a fresh metal carbenoid and ring moieties, etc. In 2004, the Hanna group reported an 
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cascade ring closing enyne metathesis in the total synthesis of guanacastepene A (Scheme 3-5).54 
 
 
Scheme 3-5. Total synthesis of guanacastepene A 
 
3.2. Design of Enyne photometathesis 
 
A good achievement of intra-cycloaddition of alkene with alkyne can give an approach for important 
cyclo-products. The enyne 28a tethered by ester group was transformed to the unexpected product, 
which was turned to be coumarin 30a in 73% yield (E/Z = 1:1; Scheme 3-6) at standard condition. We 
guessed that the formation of 1,3-diene was caused by electrocyclic ring opening of the cyclobutene 
initially formed. In addition, Without light or catalyst, there was no reaction as the control experiments. 
Therefore, the photo-promoted intramolecular cycloaddition of enyne gives an accessibility for the 
conjugated dienes with high substitution despite employing simpler substrates. This synthetic route can 





Scheme 3-6. Enyne photometathesis and control experiments 
 
Therefore, we developed a new synthetic approach of the synthesis of conjugated dienes through triplet 
tandem excitation obtaining cyclobutene products (Figure 3-3). Prepared enynes can be converted to 
1,3-dienes bearing pharmacological active molecules such as coumarin and 2-quinolone derivatives. 
Interestingly, only limited number of examples for the formation of conjugated dienes with high 
substitution via enyne metathesis have been known to date. As such, we were prompted to perform a 
comparison by using 28a. While our synthetic method afforded 1,3-diene 30a in 73% yield, Ru-
catalyzed ring closing enyne metathesis failed to attain 30a (Scheme 3-7). 
 
Figure 3-3. Enyne photometathesis under visible light 
 
 
Scheme 3-7. Comparison with Ru-catalyzed ring closing enyne metathesis 
87 
 
3.3. Substrate Scope for Enyne Photometathesis 
 




Unless other noticed, the intramolecular reactions were proceeded under blue light from 12 W LED strip and argon gas with 
0.1 mmol scale; Isolated by column chromatography. a Reaction time : 1 – 18 h b Reaction time : 24 – 48 h c 29r is racemic, 
reaction time : 60 h. d It was performed using 0.05 mmol scale; The concentration of reaction was 0.01 M. 
We examined the scope of the alkyne moiety to see that it has wide tolerability (Table 3-1). The 
substitution with p-tolyl and TMS functional groups afforded the corresponding 1,3-diene in good 
yields (30a and 30b). The substitution ester to amido tethers could be transformed to corresponding 2-
quinolones 30c - 30e in good to excellent yields. A variety type of substitution with aryl/heteroaryl and 
alkyl functional groups showed good tolerability for affording desired 2-quinolone derivatives. For 
instance, 2-quinolones 30f and 30g with heteroaryl groups were easily synthesized by using pyridine 
and isoquinoline substituted alkynes, respectively. Moreover, changes of the alkene part to a variety of 
groups containing pyridine, furan, ester, and amide gave desired product in good to outstanding yields 
(30i – 30l). The steric effect of alkene part was investigated with the enyne 28m containing a highly 
substituted alkene, which afforded 1,3-diene 30m in moderate yield. Besides amido tethers, an enyne 
with sulfonamide tether can be also transformed to be corresponding sultam 30n. Finally, we 
investigated the probability of the formation of spiro-cycles from the enynes with ester and amido-
tethers, which well afforded the corresponding conjugated dienes 30o and 30p, respectively. 
Surprisingly, the reaction of enyne 28q furnished 30q’ through electrocyclization of the initially formed 
diene as an intermediate. Furthermore, the reaction of enyne 28r with silyl tether gave unique 
cyclobutene product 29r, which is fused with 7-membered ring in 62% yield. However, other trials 
were failed to afford 1,3-dienes from enynes shown in Figure 3-4. Enynes 31 and 32 including less-
activated alkene couldn’t give desired 1,3-dienes. While silyl-tethered enyne succeeded to transform to 
7-membered ring fused cyclobutene, Enyne 33 underwent only E/Z isomerization of alkene part without 
transforming to desired product. The intramolecular reaction of enyne 28s bearing benzofuran as alkene 
part afforded an unexpected product, which was turned out to be 29s’ in 74% (Scheme 3-8). It is in 
contrast to the synthesis of 1,3-diene using other intramolecular enynes without heterocyclic substituent 
groups, which occurs via ring opening of cyclobutenes. This unique product would be obtained because 
of activation of the cyclobutene 29s provides 1,2-diradical 34, that fragmented to afford 1,5-diradical 
35 and then undergoes recombination to attain 29s’. This rearrangement can be also performed using 
enyne bearing benzothiophene 28t and 28u to give 29t’ and 29u’ in excellent yields. To see whether 
ring expansion can occur, 29t’ was heated up to 100 °C. To our satisfaction, polycyclic product 30t’ 
was given to 65% yield, that would be explained through sulfur extrusion after ring-opening of 4-
membered ring. In addition, the polycycle formation from 29u’ well achieved to afford the rearranged 






Figure 3-4. Scope of failed enynes 
 
 





3.4. Transformation of 1,3-Dienes to Phenanthrenes 
 
Scheme 3-9. Application for extended π-system compounds 
 
Extended π-system is a valuable aspect in a variety of applications such as material science and 
fluorescence sensors.55-58 Therefore, we examined the accessibility for such compounds using our 
synthetic approach (Scheme 3-9). Moreover, we proved that each phenanthrene 30a’ and 30a’’ could 
be easily synthesized using 1,3-diene 30a by oxidative electro-cyclization and benzyne [4+2] 
cycloaddition. 
 
3.5. Proposed Mechanism of Enyne Photometathesis 
To investigate whether triplet energy transfer is also operative in the intramolecular reaction, we 
compared with among selected photocatalysts (Scheme 3-10). First, we chosed PC II and VI because 
the triplet energy level of 28c (49.0 kcal/mol) is similar or lower than their triplet energy levels. 
Ruthenium catalyst and organic dye, which are shown and have lower triplet energy levels, were also 
chosen as a control. The outcomes were shown in Figure 47, which had a good agreement with triplet 
energy levels of photocatalysts. Furthermore, it’s remarkable in that photocatalyst PC VI afforded 30c 
in 67% while it was ineffective for the intermolecular cycloaddition because it had lower triplet energy 




Scheme 3-10. Screening of catalysts for enyne photometathesis 
 
In addition, we examined the reduction and oxidation potential of 28c using cyclic voltammogram, the 
reduction potential (Ep/2
red = -2.13 and -2.44 V vs SCE) seemed to be insufficient to attain reduction by 
the photocatalysts (Figure 3-5). This result proposed that the mechanism of intramolecular reaction 




ox = +1.82, +0.11 V vs SCE, Ep/2
red = -2.13, -2.44 V vs SCE 
Figure 3-5. Cyclic voltammetry of enyne 28c 
 
The result of Stern-Volmer quenching experiment using enyne 28c also showed the same trend with 
several catalysts (Figure 3-6). The degree of catalyst quenching by 28c was consistent with their triplet 
energy levels, while it was inconsistent with their redox potentials. The most noticeable quenching was 
observed using PC I with the highest triplet energy. These results show that the reaction is proceeded 




Figure 3-6. Stern-Volmer plot using 28c as a quencher 
 
To figure out whether a radical chain mechanism is in operation for the reaction, we performed light 
on-off experiments for intramolecular reaction of enyne 28d (Figure 3-7). The reaction stopped without 
light like the intermolecular cycloaddition, which excludes the radical chain process. 
 
 




In our hypothesis, triplet tandem excitation of initially formed cyclobutene derivatives might lead to 
formation of conjugated dienes (Figure 3-8). After further mechanism study such as DFT calculations, 
it was found that the cyclobutene 29c could be easily activated to the triplet state (41.2 kcal/mol) by 
that of photocatalyst PC I (60.8 kcal/mol). In summary, enyne 28c would be excited to its triplet state 
in photocatalysis to afford diradical intermediate 28c* and undergoes radical addition on alkyne moiety 
to be transformed to be Int-29c, which converts to 29c after inter system crossing process. Cyclobutene 
29c excited to its triplet state by Ir photocatalyst to attain diradical intermediate 29c*, which can have 




Figure 3-8. Reaction mechanism of enyne photometathesis 
 
3.6. Conclusion 
We developed enyne photometathesis based on tandem energy transfer photocatalysis under visible 
light. Conjugated dienes could be formed via intramolecular cycloadditions of conjugated enynes. 
Triplet tandem activation is responsible for the ring-opening from cyclobutene as an intermediate. In an 
aspect of synthetic chemistry, the photo-cycloaddition of enyne can offer alternative methods to the 
transition metal catalytic enyne metathesis resulting conjugated dienes with high substitution. This 
finding is meaningful because 1,3-diene product in the reaction can include bioactive molecules such 
as coumarin and 2-quinolone. Furthermore, We proved the applicability of our synthetic tool toward 





3.7. Experimental Procedure and Data 
Stern-Volmer luminescence quenching experiments 
Stern-Volmer luminescence quenching studies were carried out using a 0.1 mM solution of 
photocatalyst and variable concentrations of substrate in dry DCM under Ar gas at rt. Samples were 
prepared in 0.5 mL quartz cuvettes inside an argon filled glove-box, and sealed with parafilm. The 
solutions were irradiated at 420 nm and the luminescence was measured at maximum emission 
wavelength of each photocatalyst. (I0 = emission intensity of the photocatalyst in isolation at the 
specified wavelength; I = observed intensity as a function of the quencher concentration) 
 
Electrochemical measurements with cyclic voltammogram 
Electrochemical measurement : 
Samples for electrochemical measurements were prepared with 0.03 mmol of substrate in anhydrous 
degassed 0.1 M Bu4NPF6 solution in MeCN (3 mL). The corresponding cyclic voltammograms were 
collected by a Potentiostat equipped with a reference electrode (3 M KCl Ag/AgCl), counter electrode 
(platinum wire) and working electrode (glassy carbon), and 100 mV/s (scan rate); Data were analyzed 
by subtracting the electrolyte solution background current prior to identifying the maximum current 
(Cp) and determining the potential (Ep/2) at half this value (Cp/2). The obtained value was referenced to 
Ag/AgCl and converted to SCE by subtracting 0.04 V. 
 
General Procedure B (1,3-diene synthesis) 
In a dried 4 mL vial, catalyst Ir[dF(CF3)ppy]2(dtbbpy)PF6 (2.5 mol%) and enyne (1.0 equiv., 0.1 mmol) 
were equipped. The heterogenic mixture was dissolved in CH2Cl2 (2 mL) under Ar gas in the glovebox. 
And then the solution was put under blue light from 12 W LED strip at ambient temperature maintaining 
by a cooling fan. The solution was put under nitrogen blow after finishing reaction with monitoring by 
TLC technique. Column flash chromatography separated the residue on silica gel to obtain desired 
product. 
 
Synthesis of Extended π-Systems 
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Step 1 : In a dried 4 mL vial, catalyst Ir[dF(CF3)ppy]2(dtbbpy)PF6 (2.5 mol%) and enyne 28s, 28t or 
28u (1.0 equiv., 0.1 mmol) were equipped. The heterogenic mixture was dissolved in CH2Cl2 (2 mL) 
under Ar gas in the glovebox. And then the solution was put under blue light from 12 W LED strip at 
ambient temperature maintaining by a cooling fan. The solution was put under nitrogen blow after 
finishing reaction with monitoring by TLC technique. Column flash chromatography separated the 
residue on silica gel to obtain desired product 29s′, 29t′ or 29u′.  
Step 2 : Solution of 29t′ or 29u′ in o-xylene was stirred at 100 °C. The solution was put under nitrogen 
blow after finishing reaction with monitoring by TLC technique. Column flash chromatography 
separated the residue on silica gel the desired product 30t′, 30u′. 
 
To a mixture of diene 30a (0.2 mmol, 1.0 equiv.) and DDQ (2.1 equiv.) in dry CH2Cl2 (7 mL, 0.03 M) 
at 0°C was added trifluoromethanesulfonic acid (7.0 equiv.) dropwise. The reaction mixture was stirred 
at 0 °C for 3 hours. The mixture was quenched by saturated NaHCO3 solution and extracted by CH2Cl2. 
The combined organic layer was dried over Na2SO4, filtered and concentrated. Column Flash 
chromatography separated the residue on silica gel to give the desired product 30a′. 43 mg, 61% yield; 
white solid; m.p. 199 – 200 °C; 1H NMR (400 MHz, CDCl3) δ 8.57 (s, 1H), 8.54 (s, 1H), 7.80 (d, J = 
8.1 Hz, 1H), 7.64 (s, 1H), 7.55 – 7.42 (m, 4H), 7.32 (d, J = 8.3 Hz, 1H), 7.08 – 7.00 (m, 2H), 6.57 (s, 
1H), 2.67 (s, 3H), 2.63 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 160.9, 155.6, 153.7, 137.5, 136.9, 131.9, 
130.6, 130.5, 130.2, 129.0, 128.9, 128.8, 128.7, 127.8, 127.6, 126.5, 126.2, 124.2, 122.9, 122.4, 120.1, 
117.1, 116.7, 22.2, 22.0; HRMS m/z calculated for [C25H19O2]





To a solution of diene (E)-30a (0.045 mmol, 1.0 equiv.) and 2-(trimethylsilyl)phenyl 
trifluoromethanesulfonate (1.5 equiv.) in THF (0.45 mL, 0.1 M) was added cesium fluoride (4.5 equiv.). 
The reaction mixture was stirred at room temperature for 18 hours. The reaction mixture was 
concentrated under vacuum. Column Flash chromatography separated the residue on silica gel to 
obtained the desired product. 11 mg, 64% yield of 30a’’; White solid; 1H NMR (400 MHz, CDCl3) δ 
8.70 (t, J = 8.4 Hz, 2H), 8.08 (d, J = 8.3 Hz, 1H), 7.89 (d, J = 7.7 Hz, 1H), 7.69 – 7.55 (m, 3H), 7.46 
(ddq, J = 8.1, 6.9, 1.3 Hz, 1H), 7.21 (d, J = 8.1 Hz, 2H), 7.15 (d, J = 8.0 Hz, 2H), 7.04 (d, J = 7.7 Hz, 
2H), 7.00 (d, J = 7.8 Hz, 2H), 6.83 (s, 1H), 2.34 (s, 3H), 2.30 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
140.9, 140.8, 137.5, 137.0, 136.7, 134.6, 131.6, 131.2, 130.8, 130.7, 130.1, 129.5, 129.4, 129.0, 128.8, 
128.6, 127.9, 127.2, 126.7, 126.5, 126.4, 126.2, 122.8, 122.5, 76.7, 21.3; HRMS m/z calculated for 
[C30H24Na]




Prepared according to the General Procedure B using 2-(p-tolylethynyl)phenyl (E)-3-(p-tolyl)acrylate 
28a (0.1 mmol, 1.0 equiv.), 26 mg, 73% yield, (E/Z 1:1); (E)-30a: pale yellow solid; m.p. 144 – 146 °C; 
1H NMR (400 MHz, CDCl3) δ 7.53 (dd, J = 8.0, 1.5 Hz, 1H), 7.45 (ddd, J = 8.7, 7.3, 1.6 Hz, 1H), 7.34 
(dd, J = 8.3, 1.2 Hz, 1H), 7.16 – 7.06 (m, 7H), 7.03 (d, J = 8.2 Hz, 2H), 6.83 (s, 1H), 6.41 (s, 1H), 2.33 
(s, 3H), 2.32 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 161.2, 157.8, 154.2, 138.3, 138.2, 136.2, 135.0, 
133.0, 132.8, 131.6, 129.8, 129.8, 129.4, 129.1, 127.3, 124.1, 119.2, 117.3, 115.7, 21.45, 21.45; HRMS 
m/z calculated for [C25H21O2]+ ([M+H]
+): 353.1536, observed : 353.1536; (Z)-30a : pale yellow solid; 
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m.p. 76 – 77 °C; 1H NMR (400 MHz, CDCl3) δ 7.49 (t, J = 7.8 Hz, 1H), 7.47 – 7.36 (m, 2H), 7.31 (d, 
J = 8.2 Hz, 2H), 7.23 (s, 1H), 7.15 (d, J = 8.4 Hz, 2H), 7.14 – 7.09 (m, 1H), 7.05 (d, J = 8.1 Hz, 2H), 
6.98 (d, J = 8.2 Hz, 2H), 6.35 (s, 1H), 2.35 (s, 3H), 2.26 (s, 3H); 13C NMR (100 MHz, CDCl3) 160.9, 
155.5, 154.3, 138.4, 138.1, 137.2, 134.6, 133.0, 132.1, 130.9, 129.7, 129.4, 128.9, 127.1, 126.3, 124.7, 
119.2, 117.4, 117.2, 21.32, 21.28; HRMS m/z calculated for [C25H21O2]





Prepared according to the General Procedure B using 2-((trimethylsilyl)ethynyl)phenyl (E)-3-(p-
tolyl)acrylate 28b (0.1 mmol, 1.0 equiv.), 20 mg, 60% yield (E/Z 1.2:1); white solid; m.p. 103 – 116 °C; 
The NMR spectrum was obtained on a partially purified material as a mixture of E/Z isomers; 1H NMR 
(400 MHz, CDCl3) δ 7.59 (dd, J = 7.9, 1.6 Hz, 0.4H), 7.54 (ddd, J = 8.6, 7.3, 1.6 Hz, 0.4H), 7.49 (ddd, 
J = 8.6, 7.2, 1.6 Hz, 0.6H), 7.43 (dd, J = 7.9, 1.6 Hz, 0.6H), 7.37 (m, 1H), 7.32 – 7.24 (m, 1.6H), 7.20 
(d, J = 7.8 Hz, 0.8H), 7.13 (t, J = 7.6 Hz, 0.6H), 7.04 (d, J = 8.0 Hz, 1.2H), 7.00 (s, 0.6H), 6.94 (d, J = 
8.0 Hz, 1.2H), 6.16 (s, 0.4H), 6.13 (s, 0.6H), 2.39 (s, 1.2H), 2.22 (s, 1.8H), 0.16 (s, 5.4H), 0.01 (s, 3.6H); 
13C NMR (100 MHz, CDCl3) δ 161.5, 161.1, 160.9, 158.9, 153.8, 153.7, 146.4, 140.1, 140.0, 138.4, 
138.1, 138.0, 135.2, 133.3, 132.0, 131.8, 129.2, 128.9, 128.9, 128.4, 126.9, 126.7, 124.2, 124.0, 120.1, 
118.2, 117.2, 117.2, 112.1, 111.8, 21.3, 21.1, 0.3, -1.5.; HRMS m/z calculated for [C21H23O2Si]
+ 






Prepared according to the General Procedure B using (E)-N-ethyl-3-(p-tolyl)-N-(2-(p-
tolylethynyl)phenyl)acrylamide 28c (0.1 mmol, 1.0 equiv.), 30 mg, 80% yield, (E/Z 2:1); (E)-30c : 
yellow solid; m.p. 168 – 169 °C; 1H NMR (400 MHz, CDCl3) δ 7.74 (dd, J = 8.1, 1.5 Hz, 1H), 7.49 
(ddd, J = 8.6, 7.1, 1.6 Hz, 1H), 7.39 (d, J = 8.1 Hz, 1H), 7.16 (d, J = 8.1 Hz, 2H), 7.10 – 6.99 (m, 7H), 
6.74 (s, 1H), 6.73 (s, 1H), 4.39 (q, J = 7.1 Hz, 2H), 2.31 (s, 3H), 2.30 (s, 3H), 1.39 (t, J = 7.1 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 161.7, 152.8, 139.3, 137.6, 137.5, 137.4, 135.8, 133.5, 131.5, 130.3, 
129.4, 129.4, 129.2, 128.9, 128.0, 121.7, 121.6, 120.7, 114.2, 37.3, 21.25, 21.25, 12.8.; HRMS m/z 
calculated for [C27H25NNaO]
+ ([M+Na]+): 402.1828, observed : 402.1820; (Z)-30c : white solid; m.p. 
147 – 149 °C; 1H NMR (400 MHz, CDCl3) δ 7.61 – 7.39 (m, 3H), 7.33 – 7.23 (m, 3H), 7.18 (s, 1H), 
7.10 (d, J = 7.6 Hz, 2H), 7.05 (t, J = 7.4 Hz, 1H), 6.98 (d, J = 7.8 Hz, 2H), 6.90 (d, J = 7.7 Hz, 2H), 
6.63 (s, 1H), 4.49 (dq, J = 14.1, 7.1 Hz, 1H), 4.36 (dq, J = 14.1, 7.1 Hz, 1H), 2.32 (s, 3H), 2.22 (s, 3H), 
1.43 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 161.7, 149.8, 139.3, 138.0, 137.8, 137.3, 136.0, 
133.3, 130.6, 129.9, 129.3, 129.0, 128.8, 127.8, 126.1, 122.6, 122.1, 120.6, 114.3, 37.3, 21.12, 21.10, 
12.9.; HRMS m/z calculated for [C27H25NNaO]




Prepared according to the General Procedure B using (E)-3-(2-bromophenyl)-N-ethyl-N-(2-
(phenylethynyl)phenyl)acrylamide 28d (0.1 mmol, 1.0 equiv.). 32 mg, 74% yield (E/Z 1.8:1); yellow 
solid; The NMR spectrum was obtained on a partially purified material as a mixture of E/Z isomers; 1H 
NMR (400 MHz, CDCl3) δ 7.70 (dd, J = 8.1, 1.3 Hz, 0.35H), 7.59 (t, J = 7.1 Hz, 1H), 7.54 – 7.48 (m, 
1.35H), 7.46 – 7.30 (m, 3.35H), 7.20 – 7.13 (m, 3H), 7.11 – 7.00 (m, 3H), 7.01 – 6.92 (m, 0.65H), 6.93 
– 6.87 (m, 0.35H), 6.87 (s, 0.65H), 6.83 (s, 0.65H), 6.63 (s, 0.35H), 4.50 – 4.25 (m, 2H), 1.40 (m, 1.45 
–1.35, 3H); 13C NMR (100 MHz, CDCl3) δ 161.6, 161.4, 151.7, 148.5, 140.1, 140.0, 139.3, 139.1, 139.0, 
137.7, 137.2, 136.6, 132.59, 132.55, 131.4, 131.3, 130.6, 130.4, 130.3, 129.6, 129.3, 129.0, 128.9, 128.7, 
128.5, 128.4, 127.99, 127.98, 127.8, 126.94, 126.93, 126.7, 124.7, 124.6, 123.2, 122.1, 122.0, 121.8, 
120.7, 120.5, 114.4, 114.3, 37.4, 37.4, 12.9, 12.8; HRMS m/z calculated for [C25H21BrNO]
+ ([M+H]+): 






Prepared according to the General Procedure B using (E)-N-phenyl-3-(p-tolyl)-N-(2-(p-
tolylethynyl)phenyl)acrylamide 28e (0.1 mmol, 1.0 equiv.), 40 mg, 94% yield (E/Z 1.5:1); (E)-30e : 
white solid; m.p. 142 – 144 °C; 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 8.0 Hz, 1H), 7.62 (m, 2H), 
7.53 (m, 1H), 7.33 (d, J = 7.6 Hz, 2H), 7.29 – 7.21 (m, 3H), 7.10 (t, J = 7.4 Hz, 4H), 7.05 (t, J = 8.1 
Hz, 3H), 6.83 (s, 2H), 6.67 (d, J = 8.5 Hz, 1H), 2.34 (s, 3H), 2.33 (s, 3H); 13C NMR (100 MHz, CDCl3) 
δ 162.2, 153.8, 141.4, 137.8, 137.7, 137.5, 137.5, 135.8, 133.4, 131.7, 130.2, 129.9, 129.5, 129.5, 129.3, 
128.9, 128.9, 128.9, 127.4, 122.0, 122.0, 120.1, 116.3, 21.3, 21.3; HRMS m/z calculated for 
[C31H26NO]
+ ([M+H]+): 428.2009, observed 428.2009; (Z)-30e : white solid; m.p. 144 – 146 °C; 1H 
NMR (400 MHz, CDCl3) δ 7.67 – 7.51 (m, 4H), 7.40 – 7.34 (m, 4H), 7.28 (ddd, J = 8.7, 7.1, 1.5 Hz, 
1H), 7.24 (s, 1H), 7.15 (d, J = 8.0 Hz, 2H), 7.07 (d, J = 8.1 Hz, 2H), 7.03 (t, J = 7.6 Hz, 1H), 6.97 (d, 
J = 8.0 Hz, 2H), 6.71 (m, 2H), 2.36 (s, 3H), 2.27 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 162.1, 150.8, 
141.4, 137.9, 137.9, 137.7, 137.5, 136.0, 133.3, 130.2, 130.2, 130.2, 130.1, 129.4, 129.1, 129.1, 129.0, 
128.9, 128.8, 127.2, 126.2, 123.0, 122.5, 120.1, 116.3, 21.2, 21.1.; HRMS m/z calculated for 
[C31H26NO]




Prepared according to the General Procedure B using (E)-N-ethyl-N-(2-(pyridin-2-ylethynyl)phenyl)-
3-(p-tolyl)acrylamide 28f (0.1 mmol, 1.0 equiv.), 25 mg, 69% yield (E/Z 1:2.8); (E)-30f : yellow oil; 
1H NMR (400 MHz, CDCl3) δ 8.67 (ddd, J = 4.8, 1.9, 0.9 Hz, 1H), 8.12 (s, 1H), 7.60 – 7.52 (m, 2H), 
7.52 – 7.45 (m, 2H), 7.15 (ddd, J = 7.5, 4.8, 1.1 Hz, 1H), 7.11 – 7.02 (m, 3H), 6.97 (dt, J = 8.0, 1.0 Hz, 
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1H), 6.93 (d, J = 8.0 Hz, 2H), 6.70 (s, 1H), 4.53 (dq, J = 14.3, 7.2 Hz, 1H), 4.40 (dq, J = 14.0, 7.1 Hz, 
1H), 2.24 (s, 3H) 1.46 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 161.7, 156.6, 149.5, 149.0, 
139.4, 138.2, 136.7, 133.9, 132.7, 130.9, 129.5, 129.1, 127.5, 123.0, 122.3, 121.4, 120.6, 114.4, 37.5, 
21.2, 13.0; HRMS m/z calculated for [C25H23N2O]
+ ([M+H]+): 367.1805, observed : 367.1805; (Z)-30f: 
yellow oil; 1H NMR (400 MHz, CDCl3) δ 8.59 (ddd, J = 4.9, 1.7, 0.9 Hz, 1H), 7.81 (dd, J = 8.1, 1.4 
Hz, 1H), 7.56 (td, J = 7.7, 1.8 Hz, 1H), 7.50 (ddd, J = 8.6, 7.1, 1.5 Hz, 1H), 7.39 (d, J = 8.4 Hz, 1H), 
7.29 (d, J = 7.9 Hz, 1H), 7.15 (ddd, J = 7.5, 4.9, 1.1 Hz, 1H), 7.10 – 7.05 (m, 1H), 7.04 – 6.97 (m, 4H), 
6.96 (s, 1H), 6.75 (s, 1H), 4.39 (q, J = 7.1 Hz, 2H), 2.31 (s, 3H), 1.39 (t, J = 7.1 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 161.6, 158.0, 151.6, 150.0, 139.3, 138.0, 137.3, 136.3, 134.6, 132.8, 130.3, 129.5, 
128.9, 128.1, 125.0, 122.4, 122.0, 121.7, 120.7, 114.2, 37.3, 21.2, 12.7; HRMS m/z calculated for 
[C25H22N2NaO]




Prepared according to the General Procedure B using (E)-N-ethyl-N-(2-(isoquinolin-1-
ylethynyl)phenyl)-3-(p-tolyl)acrylamide 30g (0.1 mmol, 1.0 equiv.), 34 mg, 82% yield (E/Z 1.5:1); 
yellow oil; The NMR spectrum was obtained on a partially purified material as a mixture of E/Z isomers; 
1H NMR (400 MHz, CDCl3) δ 9.23 (s, 1H), 9.17 (s, 0.7H), 8.46 (s, 0.7H), 8.43 (s, 1H), 8.31 (d, J = 8.4 
Hz, 0.7H), 8.19 (d, J = 8.1 Hz, 1.1H), 8.03 – 8.00 (m, 1.7H), 7.84 (d, J = 7.8 Hz, 1.1H), 7.78 (d, J = 
8.0 Hz, 0.8H), 7.73 – 7.42 (m, 7.4H), 7.21 – 7.18 (m, 2.1H), 7.14 (s, 0.7H), 7.08 (d, J = 8.0 Hz, 1.4H), 
7.02 (t, J = 7.5 Hz, 0.7H), 6.96 (d, J = 7.9 Hz, 1.4H), 6.88 – 6.82 (m, 4.1H), 6.71 (s, 0.7H), 6.57 (s, 
1H), 4.53 – 4.28 (m, 4H), 2.26 (s, 2.1H), 2.21 (s, 3H), 1.41 – 1.35 (m, 5.2H); 13C NMR (100 MHz, 
CDCl3) δ 161.7, 161.6, 152.7, 152.5, 152.0, 150.1, 144.2, 142.8, 139.8, 139.6, 138.4, 138.3, 137.5, 
137.2, 134.1, 134.0, 133.7, 133.6, 132.9, 132.8, 131.3, 131.21, 131.17, 131.1, 130.9, 130.8, 129.4, 129.3, 
129.2, 129.2, 129.0, 128.8, 128.51, 128.46, 127.6, 127.53, 127.52, 127.4, 124.6, 124.4, 122.9, 122.2, 
122.1, 121.2, 120.5, 119.8, 114.8, 114.7, 37.6, 37.5, 21.4, 21.3, 13.0, 12.9; HRMS m/z calculated for 
[C29H25N2O]






Prepared according to the General Procedure B using (E)-N-ethyl-N-(2-(hex-1-yn-1-yl)phenyl)-3-(p-
tolyl)acrylamide 28h (0.1 mmol, 1.0 equiv.), 27 mg, 78% yield (E/Z 1.7:1); yellow oil; The NMR 
spectrum was obtained on a partially purified material as a mixture of E/Z isomers; 1H NMR (400 MHz, 
CDCl3) δ 7.78 (dd, J = 8.0, 1.5 Hz, 0.7H), 7.65 (dd, J = 8.0, 1.5 Hz, 1H), 7.59 – 7.52 (m, 1.9H), 7.44 – 
7.41 (m, 1.9H), 7.28 – 7.26 (m, 0.6H), 7.22 – 7.19 (m, 1.9H), 7.13 (ddd, J = 8.1, 7.0, 1.1 Hz, 1.3H), 
6.90 (d, J = 8.3 Hz, 2.2H), 6.86 (d, J = 8.2 Hz, 2.2H), 6.63 – 6.62 (m, 1.7H), 6.52 (s, 1H), 6.49 (s, 0.7H), 
4.53 – 4.27 (m, 4.1H), 2.66 – 2.62 (m, 1.3H), 2.52 – 2.38 (m, 4.1H), 2.19 (s, 3H), 1.52 – 1.26 (m, 13H), 
0.89 (t, J = 7.1 Hz, 3H), 0.82 (t, J = 7.2 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 161.9, 161.8, 153.3, 
151.6, 139.4, 139.3, 139.0, 137.1, 136.9, 136.7, 134.0, 133.4, 130.8, 130.7, 130.6, 129.2, 129.0, 128.9, 
128.8, 128.3, 127.6, 127.3, 122.1, 121.8, 121.0, 120.6, 120.1, 119.9, 114.5, 114.5, 40.0, 37.42, 37.39, 
32.2, 30.7, 30.4, 22.9, 22.5, 21.4, 21.2, 14.0, 13.9, 13.0, 12.9; HRMS m/z calculated for [C24H28NO]
+ 




Prepared according to the General Procedure B using (E)-N-ethyl-3-(pyridin-2-yl)-N-(2-(p-
tolylethynyl)phenyl)acrylamide 28i (0.1 mmol, 1.0 equiv.), 27 mg, 74% yield (E/Z 1.3:1); (E)-30i : 
colorless oil; 1H NMR (400 MHz, CDCl3) δ 8.60 – 8.59 (m, 1H), 7.71 (dd, J = 8.1, 1.5 Hz, 1H), 7.49 
(ddd, J = 8.6, 7.1, 1.5 Hz, 1H), 7.45 – 7.38 (m, 2H), 7.15 – 7.01 (m, 7H), 6.89 (s, 1H), 6.78 (s, 1H), 
4.40 (q, J = 7.1 Hz, 2H), 2.30 (s, 3H), 1.40 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 161.7, 
156.0, 152.1, 149.7, 141.8, 139.4, 138.4, 135.7, 135.1, 131.8, 130.6, 129.6, 129.2, 128.1, 124.5, 122.0, 




367.1805, observed : 367.1805; (Z)-30i : white solid; m.p. 131 – 133 °C; 1H NMR (400 MHz, CDCl3) 
δ 8.46 – 8.44 (m, 1H), 7.59 – 7.51 (m, 2H), 7.45 (d, J = 8.5 Hz, 1H), 7.40 – 7.30 (m, 4H), 7.13 (d, J = 
8.0 Hz, 2H), 7.08 – 7.04 (m, 1H), 6.99 – 6.94 (m, 2H), 6.64 (s, 1H), 4.50 (dq, J = 14.2, 7.1 Hz, 1H), 
4.38 (dq, J = 14.1, 7.1 Hz, 1H), 2.33 (s, 3H), 1.44 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
161.7, 155.1, 149.6, 149.5, 140.1, 139.4, 138.8, 137.1, 136.0, 130.9, 130.0, 129.6, 127.8, 126.6, 123.2, 
122.3, 122.2, 121.8, 120.6, 114.5, 37.5, 21.3, 13.1; HRMS m/z calculated for [C25H23N2O]
+ ([M+H]+): 




Prepared according to the General Procedure B using (E)-N-ethyl-3-(furan-2-yl)-N-(2-(p-
tolylethynyl)phenyl)acrylamide 28j (0.1 mmol, 1.0 equiv.), 36 mg, >99% yield (E/Z 1.2:1); brown 
viscous oil; (E)-30j : 1H NMR (400 MHz, CDCl3) δ 7.79 – 7.70 (m, 1H), 7.54 – 7.48 (m, 1H), 7.40 – 
7.38 (m, 1H), 7.32 – 7.28 (m, 3H), 7.15 – 7.08 (m, 3H), 6.71 (s, 1H), 6.62 (s, 1H), 6.32 – 6.31 (m, 1H), 
6.11 – 6.10 (m, 1H), 4.38 (q, J = 7.1 Hz, 2H), 2.35 (s, 3H), 1.38 (t, J = 7.1 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 161.8, 152.4, 151.8, 142.3, 139.4, 138.1, 136.02, 135.96, 130.5, 129.4, 129.0, 128.1, 
121.84, 121.75, 120.7, 120.2, 114.4, 111.6, 110.9, 37.5, 21.5, 12.9; HRMS m/z calculated for 
[C24H22NO2]
+ ([M+H]+): 356.1645, observed : 356.1645; (Z)-30j : 1H NMR (400 MHz, CDCl3) δ 7.55 
– 7.45 (m, 3H), 7.31 – 7.29 (m, 2H), 7.19 – 7.03 (m, 5H), 6.70 (s, 1H), 6.20 – 6.19 (m, 1H), 5.87 (m, 
1H), 4.57 – 4.35 (m, 2H), 2.32 (s, 3H), 1.46 (t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 162.0, 
151.9, 149.7, 142.5, 139.5, 138.2, 136.6, 133.9, 130.8, 129.6, 127.4, 126.0, 122.3, 122.3, 120.4, 117.0, 
114.5, 111.8, 110.6, 37.6, 21.3, 13.1; HRMS m/z calculated for [C24H22NO2]
+ ([M+H]+): 356.1645, 
observed : 356.1645. 
 




Prepared according to the General Procedure B using methyl (Z)-4-(ethyl(2-(p-
tolylethynyl)phenyl)amino)-4-oxobut-2-enoate 28k (0.1 mmol, 1.0 equiv.), 21 mg, 60% yield, (E/Z 
1.5:1); colorless oil; (E)-30k: 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 8.0 Hz, 1H), 7.51 (t, J = 7.8 
Hz, 1H), 7.39 (d, J = 8.6 Hz, 1H), 7.27 (d, J = 8.7 Hz, 2H), 7.13 (d, J = 8.0 Hz, 2H), 7.08 (d, J = 7.8 
Hz, 2H), 6.69 (s, 1H), 6.13 (s, 1H), 4.36 (q, J = 7.1 Hz, 2H), 3.71 (s, 3H), 2.23 (s, 3H), 1.39 (t, J = 7.1 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 166.1, 161.2, 151.9, 150.4, 139.4, 139.2, 133.6, 130.7, 128.9, 
128.6, 127.6, 121.9, 121.4, 120.6, 119.7, 114.4, 51.6, 37.4, 21.3, 12.7; HRMS m/z calculated for 
[C22H22NO3]
+ ([M+H]+): 348.1594, observed : 348.1590 (Z)-30k: 1H NMR (400 MHz, CDCl3) δ 7.51 
(ddd, J = 8.6, 7.1, 1.5 Hz, 1H), 7.43 (d, J = 8.9 Hz, 1H), 7.39 (dd, J = 8.0, 1.5 Hz, 1H), 7.34 (d, J = 8.3 
Hz, 2H), 7.13 (d, J = 8.6 Hz, 2H), 7.07 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H), 6.62 (s, 1H), 6.55 (s, 1H), 4.52 
– 4.34 (m, 2H), 2.34 (s, 3H), 1.39 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 165.3, 161.4, 
151.6, 148.6, 140.7, 138.9, 134.4, 130.5, 129.6, 127.1, 126.9, 122.0, 120.4, 120.3, 117.8, 114.4, 51.5, 
37.5, 21.3, 12.9; HRMS m/z calculated for [C22H22NO3]




Prepared according to the General Procedure B using N1-ethyl-N4,N4-diisopropyl-N1-(2-(p-
tolylethynyl)phenyl)maleamide 28l (0.1 mmol, 1.0 equiv.), 34 mg, 82% yield (E/Z 1:2.4); yellow oil; 
The NMR spectrum was obtained on a partially purified material as a mixture of E/Z isomers; 1H NMR 
(400 MHz, CDCl3) δ 7.52 – 7.27 (m, 7.52H), 7.14 – 7.01 (m, 4.92H), 6.77 (s, 1H), 6.76 (s, 0.5H), 6.59 
(s, 0.5H), 6.21 (s, 1H), 4.43 – 4.35 (m, 3H), 4.21 – 4.14 (m, 1.5H), 3.46 – 3.32 (m, 1.5H), 2.33 (s, 1.5H), 
2.30 (s, 3H), 1.47 – 1.36 (m, 11H), 1.26 – 1.20 (m, 5.3H), 1.13 – 1.10 (m, 1.3H), 0.85 (d, J = 6.7 Hz, 
6H); 13C NMR (100 MHz, CDCl3) δ 166.9, 165.9, 161.7, 161.4, 150.8, 148.6, 142.9, 140.1, 139.2, 139.1, 
104 
 
139.1, 138.9, 135.7, 134.3, 130.7, 130.5, 129.7, 129.3, 128.4, 128.4, 128.3, 127.7, 126.5, 126.5, 125.5, 
122.0, 122.0, 121.5, 121.4, 120.7, 120.2, 114.3, 53.5, 50.6, 45.9, 45.6, 37.5, 37.4, 30.2, 29.8, 21.4, 21.3, 
20.6, 20.3, 13.0, 12.9; HRMS m/z calculated for [C27H33N2O2]





Prepared according to the General Procedure B using (E)-N-ethyl-3-(p-tolyl)-N-(2-(p-
tolylethynyl)phenyl)but-2-enamide 28m (0.1 mmol, 1.0 equiv.), 16 mg, 43% yield (E/Z = 1.2:1); yellow 
solid; m.p. 86 – 88 °C; The NMR spectrum was obtained on a partially purified material as a mixture 
of E/Z isomers; 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 7.9 Hz, 1H), 7.54 (t, J = 7.8 Hz, 0.6H), 7.46 
– 7.37 (m, 1H), 7.34 – 7.02 (m, 8H), 6.92 (d, J = 8.0 Hz, 1.2H), 6.84 (d, J = 8.0 Hz, 1.2H), 6.75 (s, 
0.6H), 6.49 (s, 0.4H), 4.50 – 4.29 (m, 1.6H), 4.14 (dq, J = 14.1, 7.1 Hz, 0.4H), 2.32 (s, 1.2H), 2.27 (s, 
1.2H), 2.17 (s, 1.8H), 2.02 (s, 1.8H), 1.41 (t, J = 7.1 Hz, 1.8H), 1.26 (t, J = 7.1 Hz, 1.2H); 13C NMR 
(100 MHz, CDCl3) δ 161.9, 161.6, 152.0, 151.8, 143.1, 142.6, 139.4, 139.1, 138.9, 137.8, 137.4, 137.00, 
136.97, 136.2, 134.4, 133.7, 130.5, 130.0, 129.6, 129.1, 129.05, 129.01, 128.6, 128.1, 128.08, 128.04, 
127.6, 127.4, 126.8, 126.8, 122.9, 122.0, 121.6, 121.5, 121.2, 120.5, 114.4, 114.1, 37.4, 37.0, 23.4, 22.8, 
21.2, 21.0, 12.9, 12.8; HRMS m/z calculated for [C27H26NO]
+ ([M+H]+): 380.2009, observed 
4-(1,2-di-p-tolylvinyl)-1-ethyl-1H-benzo[c][1,2]thiazine 2,2-dioxide (30n) 
 
Prepared according to the General Procedure B using (E)-N-ethyl-2-(p-tolyl)-N-(2-(p-
tolylethynyl)phenyl)ethene-1-sulfonamide 28n (0.1 mmol, 1.0 equiv.), 25 mg, 60% yield (E/Z 1.3:1); 
(E)-30n: white solid; m.p.110 –111 °C; 1H NMR (400 MHz, CDCl3) δ 7.57 (dd, J = 8.0, 1.5 Hz, 1H), 
7.38 (td, J = 7.8, 7.1, 1.5 Hz, 1H), 7.28 – 7.26 (m, 1H), 7.08 – 6.99 (m, 9H), 6.85 (s, 1H), 6.78 (s, 1H), 
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4.09 (q, J = 7.1 Hz, 2H), 2.31 (s, 3H), 2.29 (s, 3H), 1.39 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 149.5, 139.6, 138.1, 138.0, 137.2, 135.1, 133.6, 133.2, 130.9, 129.9, 129.8, 129.6, 129.5, 
129.1, 122.98, 122.96, 122.6, 118.6, 41.8, 21.4, 21.4, 14.7; HRMS m/z calculated for [C26H25NNaO2S]
+ 
([M+Na]+): 438.1498, observed : 438.1498; (Z)-30n: colorless oil; 1H NMR (400 MHz, CDCl3) δ 7.48 
– 7.41 (m, 2H), 7.32 (d, J = 8.3 Hz, 1H), 7.28 – 7.26 (m, 2H), 7.19 (s, 1H), 7.14 – 7.10 (m, 4H), 7.03 – 
6.98 (m, 3H), 6.66 (s, 1H), 4.27 – 4.12 (m, 2H), 2.32 (s, 3H), 2.27 (s, 3H), 1.45 (t, J = 7.1 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 145.8, 139.8, 138.2, 138.1, 137.3, 135.2, 132.7, 131.3, 131.0, 129.6, 129.4, 
129.3, 129.1, 126.1, 123.2, 122.7, 122.4, 117.9, 40.9, 21.4, 21.3, 14.9; HRMS m/z calculated for 
[C26H25NNaO2S]




Prepared according to the General Procedure B using 1-((trimethylsilyl)ethynyl)cyclohexyl (E)-3-(p-
tolyl)acrylate 28o (0.05 mmol, 1.0 equiv.) and CH2Cl2 (5 mL, 0.01 M), 24 mg, 70% yield (E/Z 1:1); 
(E)-30o: white solid; 1H NMR (400 MHz, CDCl3) δ 7.19 (d, J = 8.1 Hz, 2H), 7.06 (d, J = 8.0 Hz, 2H), 
6.90 (s, 1H), 5.85 (s, 1H), 2.32 (s, 3H), 1.65 – 1.47 (m, 6H), 1.37 – 1.23 (m, 4H), 0.23 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 177.6, 172.1, 141.4, 138.6, 136.6, 135.6, 129.2, 129.1, 117.0, 91.7, 34.6, 24.5, 
22.3, 21.5, 0.2; HRMS m/z calculated for [C21H28NaO2Si]
+ ([M+Na]+): 363.1751, observed : 363.1762; 
(Z)-30o: white solid; 1H NMR (400 MHz, CDCl3) δ 7.17 – 7.16 (m, 5H), 5.62 (s, 1H), 2.37 (s, 3H), 
1.81 – 1.60 (m, 10H), 0.02 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 179.6, 175.3, 146.1, 138.3, 137.4, 
135.5, 129.0, 128.6, 114.9, 90.1, 34.0, 24.8, 22.3, 21.4, 1.5; HRMS m/z calculated for [C21H29O2Si]
+ 






Prepared according to the General Procedure B using (E)-N-phenyl-3-(p-tolyl)-N-(1-
((trimethylsilyl)ethynyl)cyclohexyl)acrylamide 28p (0.1 mmol, 1.0 equiv.), 25 mg, 60% yield; white 
solid; m.p. 174 – 176 °C; 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.37 (m, 3H), 7.26 – 7.23 (m, 3H), 7.21 
– 7.16 (m, 4H), 5.82 (s, 1H), 2.38 (s, 3H), 2.02 – 1.96 (m, 2H), 1.89 – 1.82 (m, 2H), 1.72 – 1.63 (m, 
2H), 1.45 – 1.27 (m, 4H), 0.06 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 172.7, 171.0, 147.1, 140.1, 138.0, 
137.8, 136.0, 131.5, 129.3, 128.9, 128.5, 128.5, 120.7, 70.3, 33.8, 25.0, 22.4, 21.4, 1.7; HRMS m/z 
calculated for [C27H34NOSi]




Prepared according to the General Procedure B using (E)-N-ethyl-3-(p-tolyl)-N-(3-(p-tolyl)prop-2-yn-
1-yl)acrylamide 28q (0.1 mmol, 1.0 equiv.), 17 mg, 54% yield; yellow oil; 1H NMR (400 MHz, CDCl3) 
δ 8.33 (s, 1H), 7.94 (d, J = 8.4 Hz, 1H), 7.49 (s, 1H), 7.37 – 7.35 (m, 3H), 7.28 (d, J = 8.0 Hz, 2H), 
4.27 (s, 2H), 3.67 (q, J = 7.3 Hz, 2H), 2.49 (s, 3H), 2.43 (s, 3H), 1.24 (t, J = 7.3 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 168.3, 137.8, 137.6, 135.0, 134.2, 134.1, 133.7, 131.8, 129.8, 129.7, 129.64, 
129.63, 128.4, 124.9, 123.0, 49.2, 37.3, 22.2, 21.5, 13.6; HRMS m/z calculated for [C22H22NO]
+ 




Prepared according to the General Procedure B using di-tert-butyl((3-(p-tolyl)prop-2-yn-1-yl)oxy)silyl 
(E)-3-(p-tolyl)acrylate 28r (0.1 mmol, 1.0 equiv.), 28 mg, 62% yield; white solid; m.p. 68 – 70 °C; 1H 
NMR (400 MHz, CDCl3) δ 7.19 (d, J = 8.0 Hz, 2H), 7.14 – 7.05 (m, 4H), 7.02 (d, J = 8.1 Hz, 2H), 5.22 
(dt, J = 15.8, 1.8 Hz, 1H), 4.95 (dt, J = 15.9, 2.3 Hz, 1H), 4.45 (d, J = 2.1 Hz, 1H), 3.61 (d, J = 1.7 Hz, 
2H), 2.32 (s, 3H), 2.31 (s, 3H), 1.07 (s, 9H), 1.06 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 69.0, 142.2, 
107 
 
138.2, 137.0, 136.5, 133.9, 130.1, 129.3, 129.3, 127.1, 127.0, 62.5, 56.1, 48.7, 27.3, 27.0, 21.3, 21.1, 
21.0.. HRMS m/z calculated for [C28H37O3Si]




28 mg, 74% yield; white solid; m.p. 152 – 153 °C; 1H NMR (400 MHz, CDCl3) δ 7.58 – 7.49 (m, 3H), 
7.43 (dd, J = 7.9, 5.7 Hz, 3H), 7.23 – 7.13 (m, 4H), 6.94 (t, J = 7.2 Hz, 2H), 4.89 (s, 1H), 4.36 (q, J = 
7.1 Hz, 2H), 2.37 (s, 3H), 1.35 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 162.0, 157.5, 151.2, 
142.0, 138.7, 137.3, 134.8, 130.6, 129.5, 129.1, 126.9, 126.1, 125.7, 125.3, 122.3, 121.6, 117.2, 115.6, 
111.3, 93.4, 60.0, 37.7, 21.4, 13.2; HRMS m/z calculated for [C26H22NO2]
+ ([M+H]+): 380.1645, 
observed : 380.1645. 
 
5-ethyl-11a-(p-tolyl)-6b,11a-dihydrobenzo[4',5']thieno[2',3':3,4]cyclobuta[1,2-c]quinolin-6(5H)-
one (29t′)  
 
40 mg, >99% yield; white solid; m.p. 146 – 147 °C 1H NMR (400 MHz, CDCl3) δ 7.64 (dd, J = 7.8, 1.5 
Hz, 1H), 7.61 – 7.55 (m, 2H), 7.46 (d, J = 8.2 Hz, 3H), 7.27 – 7.18 (m, 2H), 7.18 – 7.12 (m, 4H), 5.09 
(s, 1H), 4.35 (qd, J = 7.0, 2.6 Hz, 2H), 2.35 (s, 3H), 1.34 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 157.0, 152.8, 142.1, 141.9, 138.0, 136.6, 134.2, 131.7, 130.4, 129.4, 128.4, 127.2, 126.1, 
125.2, 125.0, 122.6, 122.1, 116.9, 115.7, 68.6, 66.9, 37.5, 21.1, 13.1.; HRMS m/z calculated for 
[C26H22NOS]






65% yield; 1H NMR (400 MHz, CDCl3) δ 9.28 (s, 1H), 8.12 (d, J = 8.0 Hz, 1H), 7.59 (d, J = 8.7 Hz, 
1H), 7.54 (ddd, J = 8.1, 6.7, 1.3 Hz, 1H), 7.47 (ddd, J = 8.3, 6.7, 1.3 Hz, 1H), 7.41 (d, J = 7.9 Hz, 2H), 
7.39 – 7.30 (m, 3H), 7.25 (d, J = 9.1 Hz, 2H), 6.78 (ddd, J = 8.4, 6.8, 1.4 Hz, 1H), 4.48 (q, J = 7.1 Hz, 
2H), 2.55 (s, 3H), 1.47 (t, J = 7.1 Hz, 3H).; 13C NMR (100 MHz, CDCl3) δ 161.7, 137.8, 137.5, 137.3, 
136.5, 135.7, 131.8, 130.31, 130.26, 130.1, 129.4, 129.3, 128.4, 128.0, 127.6, 126.9, 126.2, 124.5, 121.1, 
120.9, 114.7, 38.2, 21.5, 12.7.; HRMS m/z calculated for [C26H22NO]






33 mg, 76% yield; white solid; m.p. 205 – 206 °C 1H NMR (400 MHz, CDCl3) δ 7.99 (m, 1H), 7.87 – 
7.83 (m, 2H), 7.76 – 7.70 (m, 3H), 7.63 – 7.59 (m, 2H), 7.51 – 7.44 (m, 3H), 7.29 – 7.16 (m, 4H) 5.21 
(s, 1H), 4.41 – 4.35 (m, 2H), 1.37 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 157.2, 152.9, 
142.3, 142.2, 137.0, 134.3, 133.09, 133.05, 131.9, 130.7, 129.0, 128.7, 128.3, 127.8, 126.68, 126.67, 
126.4, 126.0, 125.47, 125.45, 125.2, 122.8, 122.4, 117.1, 115.9, 68.6, 67.4, 37.7, 13.2; HRMS m/z 
calculated for [C29H22NOS]






86% yield; 1H NMR (400 MHz, CDCl3) δ 9.33 (m, 1H), 8.15 (d, J = 8.2 Hz, 1H), 8.10 (d, J = 8.4 Hz, 
1H), 8.03 (d, J = 8.0 Hz, 1H), 7.87 – 7.85 (m, 2H), 7.64 – 7.50 (m, 5H), 7.45 – 7.41 (m, 1H), 7.39 – 
7.34 (m, 2H), 7.31 – 7.27 (m, 1H), 6.61 (ddd, J = 8.4, 7.0, 1.3 Hz, 1H), 4.50 (q, J = 7.1 Hz, 2H), 1.49 
(t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 161.8, 138.6, 137.5, 136.3, 135.8, 134.1, 132.9, 
132.0, 130.6, 129.61, 129.55, 129.5, 129.3, 128.9, 128.7, 128.4, 128.3, 128.2, 128.0, 127.0, 126.7, 126.6, 
126.5, 124.7, 121.4, 120.8, 114.9, 38.4, 12.8; HRMS m/z calculated for [C29H22NO]
+ ([M+H]+): 
400.1696, observed 400.1696. 
 
 

























Figure 3-14. HMBC of compound 30t’ 
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학위과정을 취득하는 동안 저를 도와주신 많은 분들에게 감사의 글을 적습니다. 
무엇보다도, 제게 유기화학의 매력을 알게 해 주셨고, 많이 부족한 저에게 매번 기회 
주시며 좋은 방향으로 이끌어 주신 박철민 교수님께 깊은 감사를 드립니다. 어떤 
상황에도 희망을 잃지 않으며 오기를 가지고 도전하는 제자가 되어 교수님께 그동안 
받기만 했던 가르침에 오래도록 보답하겠습니다. 그리고 제가 박사 학위를 받을 수 있게 
도와주시고 따뜻한 조언과 격려해주신 홍성유 교수님, 곽자훈 교수님, 심교승 교수님, 
주정민 교수님께도 감사의 말씀을 드립니다. 
어떤 이유 에서라도 제가 돌아갈 수 있는 든든한 쉼터가 되어주고, 저를 믿고 항상 
묵묵히 응원해주신 저희 가족 하형곤, 이미순 님께도 감사드립니다. 
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비교적 짧은 기간이었지만, 항상 밝은 모습으로 저의 잊지 못할 마지막 해를 함께 해준 
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